When coincidences outnumber differences, it’s either a method or a conspiracy. In the AIDS – Covid comparison, it’s both.
Our effort has already earned the YouTube Badge of Honor and Credibility, so you know this is hard-hitting
Let’s play a new game: Identify all the ‘coincidences’ between AIDS and Covid. Here’s my incomplete list for starters:
No gold standard virus isolation from patients
Virus – illness causation not fully evidenced
Fauci runs the show
Poison sold for therapy results in genocide
Cases explode after therapy approval
Fauci promotes Gilead drugs and suppresses all other alternatives
Deliberate misuse of PCRs
Fake test and cases
Fauci brutally suppresses dissent
Fake stats and other mish-mashes in third world
They couldn’t do it without their friends in media and Pentagon
Strong political and economical incentives for Government participation
Genetic sequence changing all the time
No cure found, normalized, need permanent medication
I will probably add more with time, feel free to send me suggestions on my socials
Mengele was a baby compared to what Fauci achieved in any of these crises alone
I only mirror AIDS and COVID / AZT and Covid injections here, but rest assured they’ve made many more trials and versions, these are just the most documented and obvious. So much documented I might follow up with one or two more episodes. However, these first 40+ minutes suffice to support the claim in my headline and the case that trialing Fauci’s genocide has to start with AIDS, if not earlier. But this video presentation is not all I have, I’ll keep adding below more of the bombshells I’ve dug out during my investigations.
To be continued? Our work and existence, as media and people, is funded solely by our most generous supporters. But we’re not really covering our costs so far, and we’re in dire needs to upgrade our equipment, especially for video production. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
THERE’S NO BETTER PREVENTION THAN SHARING THE KNOWLEDGE FASTER THAN THEY SHARE THEIR PROPAGANDA!
The original title of this article was URGENT! DEBUNKING THE NEXT ENGINEERED PANDEMIC: NIPAH VIRUS. I expanded the scope because in the meantime I learned they are ramping up propaganda for all three. These viruses have more things in common, as you will find out below.
You should actually begin with this earlier report:
To further develop the ChAd3 Ebola and Marburg vaccines, Sabin has entered into a Research Collaboration Agreement with the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases. The Sabin Vaccine Institute, a non-profit organization founded in 1993, is a leading advocate for expanding vaccine access and uptake globally, advancing vaccine research and development, and amplifying vaccine knowledge and innovation. Sabin received more than $110 million for vaccine R&D programs from public and philanthropic funding sources, including the Bill & Melinda Gates Foundation, European Commission, Dutch Ministry of Foreign Affairs, Global Health Innovative Technology Fund and the Michelson Medical Research Foundation.
Washington DC, Oct. 21, 2021 (GLOBE NEWSWIRE) — The Sabin Vaccine Institute (Sabin) announced that the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services, has exercised the third contract option, valued at $34.5 million, under the 2019 contract to advance the development of vaccines against Ebola Sudan and Marburg viruses through Phase 2 clinical trials.
In September 2019, BARDA awarded Sabin a development contract, valued up to $128 million, and has already provided funding of $40.5 million. This third contract option will enable continued nonclinical efficacy and safety studies, Phase 2 clinical trials in Africa, and vaccine manufacturing processes to ensure quality and safety.
In August, a case of Marburg disease was confirmed in the West African country of Guinea where the Ministry of Health officially declared an outbreak of Marburg.1 This recent case, as well as Marburg’s history of outbreaks and their potential for future devastating outbreaks, demonstrates that preventative measures are overdue to protect civilian populations, military personnel, first responders, health care workers and laboratory workers, both in the United States and abroad, against these emerging infectious diseases.
Ebola Sudan and Marburg viruses are closely related to Ebola Zaire virus, which has caused more than 2,200 deaths since 2018, leading the World Health Organization (WHO) to declare it a Public Health Emergency of International Concern. Like Ebola Zaire, Ebola Sudan and Marburg are among the world’s deadliest viruses, causing hemorrhagic fever with subsequent death in an average of 50 percent of cases.2,3
“Even as the world struggles with the COVID-19 pandemic, disease caused by Ebola Sudan and Marburg viruses continue to be a serious threat, as we have seen with the recent outbreak of Marburg in Guinea. We are grateful for BARDA’s continued support of Sabin’s efforts to advance vaccines against these deadly viruses,” said Sabin Chief Executive Officer Amy Finan. “We also thank our partners at the Vaccine Research Center of the NIH National Institute of Allergy and Infectious Diseases for their continued collaboration, and GSK for their earlier work on the candidates.”
The two candidate vaccines, based on GSK’s proprietary ChAd3 platform, were exclusively licensed to the Sabin Vaccine Institute from GSK in 2019.
This project has been funded in whole or in part with federal funds from the U.S. Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority, under contract number 75A50119C00055.
This above is the official Sabin Inst. press release, this below isn’t:
November 4, 2021 – The U.S. CDC published a Level Three Travel Advisory for the recent Ebola outbreak in the Beni Health Zone of the Democratic Republic of the Congo.
November 3, 2021 – The U.S. CDC vaccine advisory committee reviewed previous recommendation preexposure vaccination with Ervebo for adults aged ≥18 years in the U.S. population who are at highest risk for potential occupational exposure to Ebola virus species Zaire ebolavirus because they are: responding to an outbreak of Ebola Virus Disease (EVD), or work as health care personnel at federally designated Ebola treatment centers in the U.S., or work as laboratorians or other staff at biosafety level 4 facilities in the U.S.
November 2, 2021 – The WHO reported additional cases and deaths confirmed in the Ebola virus disease outbreak in the Democratic Republic of the Congo with two new health areas affected. A total of 394 people (67 primary care providers including nine high-risk contacts, nine contacts of contacts, and 49 probable contacts) have been vaccinated including 182 contacts of contacts, 125 probable contacts, and 87 high-risk contacts.
October 29, 2021 – A Research Article – Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomized, placebo-controlled Phase II clinical trial in Africa – was published by the journal PLOS Medicine. Conclusion – The Ad26.ZEBOV and MVA-BN-Filo combo vaccination were well tolerated and immunogenic in healthy and HIV-infected African adults. Increasing the interval between vaccinations from 28 to 56 days improved the magnitude of humoral immune responses. Antibody levels persisted to at least 1 year, and an Ad26.ZEBOV booster vaccination demonstrated the presence of vaccination-induced immune memory. These data supported the approval by the European Union for prophylaxis against EBOV disease in adults and children ≥1 year of age.
October 27, 2021 – IAVI announced an award of up to US$126 million from the Biomedical Advanced Research and Development Authority to develop two recombinant vesicular stomatitis virus (rVSV)-vectored filovirus vaccine candidates. This award supports preclinical activities and includes options for clinical development up to and inclusive of a Phase II clinical trial of IAVI’s rVSV Sudan ebolavirus vaccine candidate (rVSVΔG-SUDV-GP). Optional work that would continue the development of IAVI’s Marburg virus vaccine candidate (rVSVΔG-MARV-GP) that is currently supported by the Defense Threat Reduction Agency of the U.S. Department of Defense could be funded at a later date.
“Vectored” means, most likely, mRNA or some other genetic / nanotech targeting technology.
October 20, 2021 – The WHO African Region reported 5 Ebola cases, and over 27,000 travelers have been screened in the DRC. Furthermore, over 116 people have been vaccinated.
October 17, 2021 – Africa News reported Ebola vaccinations started in Beni, DRC, after at least two people died due to the virus in October 2021. The WHO African Region Tweeted DRC Situation Report (17/10/21) 5 confirmed cases, three deaths, 369 contacts identified, and 308 contacts monitored.
October 13, 2021 – Democratic Republic of the Congo (DRC) health officials confirmed an Ebola vaccination campaign had launched in the North Kivu province where one confirmed Ebola case, plus three related suspected deaths, were recently reported. About 1,000 doses of the rVSV-ZEBOV Ebola vaccine and other medical supplies were delivered from the capital Kinshasa to Goma city in North Kivu. The DRC has more than 12,000 vaccine doses in Kinshasa that can be deployed if necessary.
October 10, 2021 – The WHO reported additional Ebola cases related to the recent DRC case of a 3-year-old boy. A cluster of three deaths (two children and their father) who were neighbors of the case. These three patients died on 14, 19, and 29 September 2021 after developing symptoms consistent with Ebola. However, none were tested for the virus. As of October 9th, a total of 148 contacts have been identified and are under follow-up by the local response team.
October 8, 2021 – A case of Ebola has been confirmed in the eastern Democratic Republic of the Congo, five months after the end of the most recent Ebola outbreak there. The child died on October 6th. It was not immediately known if the Ebola case was related to the 2018-20 outbreak that killed more than 2,200 people in eastern Congo or the flare-up that killed six people in 2021.
September 13, 2021 – A new study based in Sierra Leone concluded the Ebola vaccine regimen from Janssen – J&J. It was found well tolerated with no safety concerns in children aged 1–17 years and induced robust humoral immune responses, suggesting the suitability of this regimen for Ebola virus disease prevention in children.
August 31, 2021 – The government of Cote d’Ivoire has informed the WHO that a second laboratory has tested samples from a patient suspected of having Ebola and has found no evidence of the virus. Around a dozen WHO experts were mobilized to support the country’s efforts, and 5,000 Ebola vaccine doses which WHO had helped Guinea procure were sent from Guinea to Cote d’Ivoire.
August 23, 2021 – The WHO African region reported Ebola booster dose vaccinations in Sierra Leone following administration of the prime dose of the Johnson & Johnson Ebola vaccine in May 2021. Frontline health workers, practitioners of traditional medicines or traditional healers, and commercial motorbike riders who received the first dose are now given their second jab to maximize their protection against the disease.
August 17, 2021 – The WHO confirmed Cote d’Ivoire deployed 2,000 vaccine doses from Merck and around 3,000 vaccine doses manufactured by Johnson & Johnson – Janssen.
August 14, 2021 – The WHO Africa reported the Ministry of Health of Cote d’Ivoire today confirmed the country’s first case of Ebola since 1994. This came after the Institut Pasteur in Cote d’Ivoire confirmed the Ebola Virus Disease in samples collected from a patient hospitalized in Abidjan’s commercial capital after arriving from Guinea.
August 9, 2021 – The WHO confirmed ‘Marburg virus disease (MVD) is a highly virulent, epidemic-prone disease associated with high case fatality rates (CFR 24-90%). In the early course of the disease, the clinical diagnosis of MVD is difficult to distinguish from other tropical febrile illnesses because of the similarities in the clinical symptoms. Differential diagnoses to be excluded include Ebola virus disease, as well as malaria, typhoid fever, leptospirosis, rickettsial infection, and plague.’
June 15, 2021 – The Southwest National Primate Research Center at Texas Biomedical Research Institute (Texas Biomed) has been awarded more than $37 million from the U.S. National Institutes of Health to continue operations into 2026. The P51 grant, given by the NIH Office of Research Infrastructure Programs, provides essential funding to house and care for nearly 2,500 non-human primates that are part of life-science research programs at Texas Biomed and partners around the globe.
June 4, 2021 – Johnson & Johnson welcomed a new recommendation by the Strategic Advisory Group of Experts on Immunization for the WHO that supports the use of the Johnson & Johnson Ebola vaccine regimen both during outbreaks for individuals at some risk of Ebola exposure and preventively, in the absence of an outbreak, for national and international first responders in neighboring areas or countries where an outbreak might spread.
April 10, 2021 – The government of Sierra Leone and the WHO announced Johnson & Johnson had donated about 4,500 Zabdeno and Mvabea Ebola vaccines to Sierra Leone to help prevent any Ebola outbreak. The last Ebola outbreak in Sierra Leone was in 2016.
March 25, 2021 – Ohio Gov. Mike DeWine revealed health officials are monitoring 44 people who have returned from areas of Africa with active outbreaks of Ebola.
March 25, 2021 – Oregon public health officials announced they are monitoring four people who recently visited the West African countries of Guinea and the Democratic Republic of the Congo. Regions in each of these countries are currently experiencing outbreaks of Ebola virus disease. The Oregon Health Authority and local public health departments have been in contact with these individuals, considered “persons under monitoring” since they arrived in the state earlier in March 2021.
March 23, 2021 – The WHO African Region Tweeted Guinea Ebola outbreak Situation Report (22/03/21) 18 cases, nine deaths, 78 contacts, 82% monitored. And 3,905 people have been vaccinated.
March 13, 2021 – After a request from the Guinean authorities, Russia is considering supplying a domestic vaccine against the Ebola virus to the African country, reported TASS.
May 13, 2020 – BARDA Provides the Sabin Vaccine Institute with an Additional $20 Million for Further Development of Ebola Sudan and Marburg Vaccines
The Sabin Vaccine Institute (Sabin) and its partner ReiThera Srl today announced that the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services, has exercised the first two options, valued at $20 million, under the 2019 contract to advance the development of vaccines against Ebola Sudan and Marburg viruses through Phase 2 clinical trials. In September 2019, BARDA awarded Sabin a development contract, valued at $128 million, and provided the initial funding award of $20.5 million. This second $20 million award will enable the manufacture and release of clinical vaccine material developed by ReiThera, a specialist in the development and cGMP manufacture of adenoviral vector vaccines. The funding will also support non-clinical studies to evaluate efficacy and immune response.
UPDATE 5: NOVEMBER 7, 2021: MARBURG GOES VIRAL ON INTERNET ONLY, YET. I’m happy awareness increases, it’s crucial. I’ve addressed this virus below, but not many had the patience to go through all text, and I kind of understand them, but there’s no easier way than reading. Here’s another angle to keep in sight when computing all this info:
UPDATE 4: OCTOBER 19 2021: THE FEARPORN CAMPAIGN TAKES SPEED AS IF THEY ARE TO RELEASE THIS SOON. IF YOU FALL FOR THEIR BRAINWASH, THEY HAVE NO REASON TO STOP.
And they’re still not running out of stupid ideas we can see through:
Oh, look who pushes the fear! Exactly who I would’ve expected:
Later update: In the meantime I’ve learned that Marburg (an Ebola relative) and Xinjiang fever, a Chinese relative of the Yellow Fever virus, are also top candidates, and that goes in line with the Fauci e-mails I highlighted below. I will be back with more details shortly. Almost certainly it will be some form of hemorrhagic fever, most likely to cover for injections side-effects on the blood stream.
UPDATE 2:
One month later, they’re starting to catch up and it’s still not too late to un-play it if this goes BOOM NOW!
By the end of last century, The Military has abandoned you and has joined Pharmafia and the super-rich elites in a plan to govern you with bioweapons and psy-ops. As I’ve said many times, Big Pharma and Big Tech are long gone, The Military BioTech Complex has been running the show for quite a while. This is just a chapter from that book, more to come if we get some love.
Canadian lab’s shipment of Ebola, Henipah viruses to China raises questions
Henipah and Nipah are interchangeable
Scientists at the National Microbiology Lab sent live Ebola and Henipah viruses to Beijing on an Air Canada flight March 31, and while the Public Health Agency of Canada says all federal policies were followed, there are questions about whether that shipment is part of an ongoing RCMP investigation.
Ebola and Henipah are Level 4 pathogens, meaning they’re some of the deadliest viruses in the world. They must be contained in a lab with the highest level of biosafety control, such as the one in Winnipeg.
Two months after that shipment, on May 24, the Public Health Agency of Canada (PHAC) referred an “administrative matter” to RCMP that resulted in the removal of two Chinese research scientists — Xiangguo Qiu and Keding Cheng — and several international students on July 5.
Both agencies have said repeatedly that public safety has not been at risk.
PHAC will not confirm if the March 31 shipment is part of the RCMP investigation.
Strict protocols
Several sources, who have asked to remain anonymous because they fear for their jobs, say the pathogens may have been shipped to the Chinese Academy of Sciences in a way that circumvented the lab’s operating procedures, and without a document protecting Canada’s intellectual property rights.
Researchers working at the National Microbiology Lab on cutting-edge, high-containment research are not allowed to send anything to other countries or labs without the intellectual property office negotiating and having a material transfer agreement in place, in case the material sent leads to a notable discovery.
A PHAC spokesperson did not confirm if this shipment included such an agreement.
However, Eric Morrissette said it’s “routine” for the lab to share samples of pathogens and toxins with partners in other countries to advance scientific work worldwide.
“All transfers of Risk Group 4 samples follow strict transportation requirements and are authorized by senior officials at the lab and the NML tracks and keeps electronic records of all shipments of samples in accordance with the HPTA. Agreements for the transfer of materials are determined on a case-by-case basis,” Morrisette wrote in an email statement.
“On the specific shipments to China earlier this year, we can confirm that we have all records pertaining to the shipment, and that all protocols were followed as directed by the above Acts and Standards.”
Xiangguo Qiu is head of the National Microbiology Lab’s Vaccine Development and Antiviral Therapies section in the Special Pathogens Program. She is responsible for the lab that works with Ebola. Her husband, Keding Cheng, is also a PHAC biologist.
After their security clearance was revoked and they were escorted from the lab, the University of Manitoba also cut ties with them and re-assigned Qiu’s graduate students, pending the RCMP investigation. No charges have been laid.
Neither scientist has responded to requests for comment, although some of their former colleagues say Qiu is not just a world-renowned scientist who helped develop a treatment for Ebola, but also a researcher with ethics and integrity.
Case raises questions
One question raised by this case is that of intellectual property protection, says Leah West, who practises, studies and publishes in the field of national security law and lectures at the Norman Paterson School of International Affairs.
“If China was leveraging these scientists in Canada to gain access to a potentially valuable pathogen or to elements of a virus without having to license the patent … it makes sense with the idea of China trying to gain access to valuable IP without paying for it,” she said.
West accepts PHAC’s assertion that public safety is not an issue, even though the viruses were transported on a commercial Air Canada flight.
However, she says the fact the RCMP is involved means there’s a legitimate concern.
“You don’t send a policy breach, a bureaucratic policy breach, to the RCMP to investigate unless you believe that that policy breach has resulted in a criminal offence or could have resulted in a criminal offence. So what is the criminal offence potentially here?” West said.
She said she hopes the lab and Health Canada are also doing an internal investigation.
“I think there will need to be an inquiry into the scientists to potentially see whether or not they were compromised or any elements of their work were compromised and that China gained illegal or improper access to Canadian intellectual property … to see what China may have gained access to without knowledge, prior to this incident,” West says.
Don’t ‘jump into any conclusions too quickly’
However, the deputy director of the University of Alberta’s China Institute is urging caution when it comes to making assumptions.
Jia Wang doesn’t dispute China has been involved in the past in espionage and intellectual property theft, but she says that country is making big investments in developing STEM (science, technology, engineering and mathematics) scholars and then putting that into innovation.
China has its own reasons to protect intellectual property because many new ideas are coming from there, Wang says.
She’s waiting to see what comes of the RCMP investigation of the lab in Winnipeg.
“As China observers, we’d like to perhaps gently remind people not to jump into any conclusions too quickly,” she said.
“It will be good to get to the bottom of this and see what might have gone wrong and what was the oversight and how can the procedures be improved or people involved can be reminded of how to adhere to the policies better.”
The shipment of the viruses took place at a time when relations between Canada and China have been strained over the arrest of a Huawei executive, at the request of the United States.
In retaliation, China has detained two Canadians and is boycotting Canadian canola and pork.
Because of the strained relationship between the two countries, and this case at the lab, Chinese-Canadian researchers and academics are starting to worry they may be singled out and targeted, Wang said.
“Certain assumptions are made or their loyalty to Canada is questioned in any way. And as multicultural as we are in Canada, we don’t want to see that.” – CBC, 2019
On December 19, 2019, the U.S. Food and Drug Administration announced the approval of Ervebo to prevent EVD caused by Zaire ebolavirus in individuals 18 years of age and older. This report, published by the U.S. CDC on January 8, 2021, summarizes the Advisory Committee on Immunization Practices (ACIP) recommendations for using the rVSVΔG-ZEBOV-GP Ebola vaccine (Ervebo) in the USA.
On July 1, 2020, the European Medicines Agency granted Johnson & Johnson Janssen’s Zabdeno and Mvabea Ebola vaccine therapy, a prime-boost vaccination approach for preventing infectious diseases. Janssen’s Ebola vaccine regimen is specifically designed to induce long-term immunity against the Ebola virus in adults and children aged one year and above.
CanSino Biologics’s Ad5-EBOV Ebola vaccine received approval in China in October 2017. Ad5-EBOV is an adenovirus type 5 vector-based Ebola virus disease vaccine that protects against Ebola by relying on the recombinant replication-defective human adenovirus type-5 vector immune response. In addition, Ad5-EBOV is manufactured as a lyophilized powder, highly stable, and does not require storage at ultra-low temperatures. This feature renders it viable for use in resource-limited tropical areas.
The WHO published the revised Ebola Vaccine FAQ on January 11, 2020.
Henipaviruses belong to the family of paramyxoviruses. Two species have been identified to be zoonotic, causing disease in animals. These are the Hendra virus (HeV) and the Nipah virus (NiV). They produce severe and often fatal illness in humans and horses.
Samples from early Wuhan COVID-19 patients show the presence of genetically modified Henipah virus, an American scientist has found.
Henipah was one of the two types of viruses sent to China by Chinese-born scientists from a Canadian laboratory at the centre of a controversy over the firing of the scientists and collaboration with Chinese military researchers. It is not clear whether the virus found in the Chinese samples is related to the samples sent by the Canadian lab, which were shipped in late March 2019.
The finding was confirmed for The Epoch Times by another qualified scientist.
The evidence was first found by Dr. Steven Quay, a Seattle-based physician-scientist and former faculty member at the Stanford University School of Medicine, who looked at early COVID-19 samples uploaded by scientists at the Wuhan Institute of Virology (WIV) shortly after China informed the World Health Organization about the SARS-CoV-2 outbreak.
Chinese virologist Shi Zhengli is seen inside the P4 laboratory in Wuhan, China, on Feb. 23, 2017. (Johannes Eisele/AFP via Getty Images)
The samples from the patients, who reportedly were found to have the “unknown pneumonia” in December 2019, were uploaded to the genetic sequence database, GenBank, on the website of the U.S. National Institute of Health (NIH).
Quay says that while other scientists around the world were mostly interested in examining the genome of SARS-CoV-2 in the samples uploaded by the WIV scientists, he wanted to see what else was in the samples collected from the patients.
So he collaborated with a few other scientists to analyze sequences from the samples.
“We started fishing inside for weird things,” Quay told The Epoch Times.
What they found, he says, are the results of what could likely be contamination from different experiments in the lab making their way into the samples, as well as evidence of Henipah virus.
“We found genetic manipulation of the Nipah virus, which is more lethal than Ebola.” Nipah is a type of Henipah virus.
The Epoch Times asked Joe Wang, PhD, who formerly spearheaded a vaccine development program for SARS in Canada with one of the world’s leading pharmaceutical companies, to verify the finding. Wang is currently the president of NTD Television Canada, the sister company of The Epoch Times in Canada.
After examining the evidence, Wang said he was able to replicate Quay’s findings on the Henipah virus. He explains that the genetic manipulation of the virus was likely for the purposes of vaccine development.
Winnipeg Lab
The firing of Chinese-born scientist Xiangguo Qiu and her husband, Keding Cheng, from the National Microbiology laboratory (NML) in Winnipeg has been the subject of much controversy in Canada, with opposition parties pressing the government for more details on the case, and the government refusing to release information citing national security and privacy concerns.
Qiu and Cheng along with several Chinese students were escorted out of NML, Canada’s only Level 4 lab, in July 2019, amid a police investigation. The two scientists were formally fired in January 2021.
The Public Health Agency of Canada (PHAC), which is in charge of NML, said the termination was the result of an “administrative matter” and “possible breaches of security protocols,” but has declined to provide further details, citing security and privacy concerns.
House Speaker Anthony Rota admonishes Public Health Agency of Canada President Iain Stewart in the House of Commons on June 21, 2021, for failing to provide documents related to the firing of two scientists from the National Microbiology Laboratory in Winnipeg. (The Canadian Press/Sean Kilpatrick)
During her time at NML, Qiu travelled several times in an official capacity to WIV, helping train personnel on Level 4 safety. The Globe and Mail later reported that scientists at NML have been collaborating with Chinese military researchers on deadly pathogens, and that one of the Chinese military researchers worked at the high-security Winnipeg lab for a period of time.
Documents and emails released by PHAC show that the shipment of Henipah and Ebola samples was done with the permission of NML authorities.
In one of the emails sent in September 2018, David Safronetz, chief of special pathogens at PHAC, informs then-head of NML Matthew Gilmour and other lab administrators about the request from WIV for the shipment of the samples, saying “I trust the lab.”
In response, Gilmour asks about the nature of the work that will be done at the Wuhan lab, and why the lab doesn’t get the material from “other, more local labs.” He also tells Safronetz that it’s “good to know that you trust this group,” asking how NML was connected with them.
In his reply, Safronetz doesn’t specifically say what the samples will be used for in China, but notes they will only be sent once all paperwork and certification is completed. He also says the WIV is requesting the material from NML “due to collaboration” with Qiu.
He adds, “Historically, it’s also been easier to obtain material from us as opposed to US labs. I don’t think other, closer labs have the ability to ship these materials.”
Gilmour resigned from his position at NML in May 2020 and joined a UK-based bioresearch company.
MPs have asked NML management why shipment of the samples was allowed and whether they knew if China performs any Gain of Function (GoF) research at WIV. GoF research involves increasing the lethal level (virulence) or transmissibility of pathogens.
NML’s acting scientific director general Guillaume Poliquin told MPs during a parliamentary committee meeting on March 22 that the lab only sent the samples to WIV after receiving assurance that no GoF research would take place.
Conservative MP John Williamson pressed for more answers, saying the word of the state-run Chinese lab can’t be trusted as the Chinese regime “has a history of theft and lies.”
The issue of GoF research at WIV has been a point of contention in the United States between lawmakers and Dr. Anthony Fauci, NIH’s head of the National Institute of Allergy and Infectious Diseases, whose organization has funded research (through EcoHealth Alliance) on coronaviruses at the Wuhan lab. U.S. Sen. Rand Paul says published work from WIV on coronaviruses shows the lab is conducting GoF research, a charge Fauci denies.
The P4 laboratory on the campus of the Wuhan Institute of Virology in Wuhan, China, on May 13, 2020. (Hector Retamal/AFP via Getty Images)
The Epoch Times sought comment from PHAC, including as to how the agency addressed issues of intellectual property and the development of any products such as vaccines with WIV, but didn’t hear back by time of publication.
Despite repeated requests by opposition parties for more details related to the firing of the two NML scientists, the Liberal government has refused to provide records, saying there are national security and privacy concerns.
After the House of Commons issued an order for the government to disclose the information, the government took the Speaker of the House to court to obtain confirmation from a judge that it can withhold the documents. The government later dropped its court case once Prime Minister Justin Trudeau called an election and Parliament was dissolved. – Epoch Times
UPDATE 3: I FOUND CREDIBLE SOURCES FOR MOST OF DR. ARYANA LOVE’S EXPLOSIVE CLAIMS BELOW:
I didn’t have an in depth look at all her sources, I can’t have a final 100% verdict, but I did more than a glance and no lies detected. You can review her blog post yourself HERE. This might be the closure to this report and the start for another.
OBAMA: EBOLA RESPONSE A TRIAL RUN FOR A POTENTIAL AIRBORNE VIRUS THAT MIGHT HIT SOON (2014)
BONUS
This is from 2014, but the story goes a way long back. And forward. Let’s not forget Putin is a Davos regular since before he became such a literal czar.
WHERE IT’S AT EXACTLY TWO YEARS LATER (SEPT. 2023)
meanwhile, we found out that…
In March 2015, a CureVac investor, the Bill & Melinda Gates Foundation, agreed to provide separate funding for several projects to develop prophylactic vaccines based on CureVac’s proprietary mRNA platform… n July 2020, Tesla, Inc CEO Elon Musk announced via Tweet that Tesla and CureVac had reached an agreement to produce portable “RNA microfactories” based on this technology to manufacture CureVac’s COVID-19 vaccine candidate. CureVac had stated that the bioprinters would be able to produce “more than a hundred thousand doses” within approximately two weeks. At approximately the same time, Tesla and CureVac filed a joint patent on the technology. In August, Musk reviewed the project with Curevac while in Germany.
How much of the tsunami is fabricated in Musk’s factories?
So we’re back at:
To be continued? Our work and existence, as media and people, is funded solely by our most generous supporters. But we’re not really covering our costs so far, and we’re in dire needs to upgrade our equipment, especially for video production. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
You thought Magnetogenetics are scary? Optogenetics are a similar thing, but using light instead of electromagnetism, non-invasive and non-detectable. Both stem from DARPA’s BRAIN Initiative. And you may be able to avoid EMF radiation, but you can’t avoid light.
(BIOHACKING P.6)
This actually touches on a wide array of concerns, from LEDs to vaccines, The Great Reset and the smart grid. I am very confident that if you pay attention to this video presentation from start to end, you will spend one hour, but you will save incommensurably more hours of guessing, wondering and researching. Not just the many hours I spent doing this, but the many more hours I learned where to look for and how to connect things. You’re still supposed to not take my word and do your own research, but this will give you some of the best tips on the topic.
Oh, so much wow! just hours after putting this out I find out they will be spraying us with viruses. Shocker!
By rendering individual neurons photosensitive, Deisseroth’s technique brings a once unthinkable level of precision and control to experiments designed to determine how the brain processes information and drives behavior.
DARPA Awards $21.6M to Develop Optogenetic ‘Read-Write’ Neural Interface
Ehud Isacoff of the Molecular Biophysics and Integrated Bioimaging (MBIB) Division is the project lead on a $21.6 million grant awarded to UC Berkeley as part of the Defense Advanced Research Projects Agency’s (DARPA’s) Neural Engineering System Design program. The team led by Isacoff, director of the Helen Wills Neuroscience Institute at UC Berkeley, aims to develop a novel brain-machine interface that uses light to monitor and modulate the activity of thousands to millions of individual neurons in the cerebral cortex.
To communicate with the brain, the team will first introduce a gene encoding a fluorescent protein into neurons, making the cells flash when they fire an action potential. This will be accompanied by a second gene encoding a light-activated protein that stimulates neurons in response to pulses of light. The reading device Isacoff’s group is developing is a miniaturized light field microscope, which captures light through an array of lenses and reconstructs images computationally in any depth of focus. For the writing component, they are developing a means to stimulate groups of neurons by projecting three-dimensional light patterns onto them.
The researchers’ goal during the initial four-year funding period is to create a prototype device using model organisms—such as zebrafish larvae and mice—in which neural activity and behavior can be simultaneously detected and controlled. But DARPA’s ultimate goal is to accelerate the development of biocompatible neural implants for use in humans to compensate for sensory deficits or to control prosthetic devices. Read more from the UC Berkeley News Center.
To be continued? Our work and existence, as media and people, is funded solely by our most generous supporters. But we’re not really covering our costs so far, and we’re in dire needs to upgrade our equipment, especially for video production. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
If you’re the kind of people who read this kind of websites, you should be aware of the fact that the US government has branded both of us as ‘terror threats’. They have also branded skepticism and dissidence as ‘mental illnesses’ or ‘psychological disorders’ before. Complying with their standards and wanting to show a collaborative side I’ve just discovered in myself, I’d like to rat on some organization that has caused tremendous damage and setbacks to ‘covid measures’.
Now, if anyone knows where I should file my report officially, please fax me the contacts!
To be continued? Our work and existence, as media and people, is funded solely by our most generous supporters. But we’re not really covering our costs so far, and we’re in dire needs to upgrade our equipment, especially for video production. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
UPDATE: Our article went viral and then they halved our traffic with their typical false-check scams. But we still have enough readers to reverse this if you get involved and share.
UPDATE 2: FACTCHECK.ORG JOINED POLITIFACT IN THE CENSORSHIP BLOCKADE
Joe Biden said in December that “my son, my family will not be involved in any business, any enterprise, that is in conflict with or appears to be in conflict, with the appropriate distance from, the presidency and government.” He promised during an Iowa campaign event in October 2019 that “no one in my family will have an office in the White House, will sit in on meetings as if they are a Cabinet member, will, in fact, have any business relationship with anyone that relates to a foreign corporation or a foreign country — period, period, end of story.”
<<Hunter Biden still appears to hold an ownership stake in a Chinese government-linked investment firm despite repeated pledges from President Joe Biden that his family would not have any foreign business ties.
That’s despite White House press secretary Jen Psaki in February saying the president’s son “has been working to unwind” his 10% stake in the firm.
Through one of his lawyers, George Mesires, Hunter Biden had promised to leave the board of the Chinese firm by the end of October 2019, but his resignation was submitted to China’s National Credit Information Publicity System in the spring of 2020. Three Chinese business websites, run by Baidu , Qixin , and QCC , all show updates with Hunter Biden’s name being removed from the BHR board of directors in April 2020, but the sites also currently show a limited liability corporation, Skaneateles, owned solely by Hunter Biden, as still being a “sponsor/shareholder” with 3 million yuan ($464,000) invested in the company, purportedly comprising a 10% stake in the China-based business venture.
The business records for Skaneateles found on the Department of Consumer and Regulatory Affairs website list Hunter Biden as the “executing officer” of the company, and the address for the LLC is a multimillion-dollar home in Hollywood Hills, Los Angeles. That is where the Washington Examinerpreviously reported Hunter Biden and his wife, Melissa Cohen, had been renting a $12,000-a-month home. A report in June said Hunter had moved on from the rental.
Business records show that U.S.-based Thornton Group and Ulysses Diversified each also holds a 10% stake in BHR, as does China-based Angju Investment Consulting (Shanghai) Company. Two Chinese companies, Bohai Industry Investment Fund Management and Shanghai Fengshi Financial Services, are listed as owning 30% of BHR each.
A review of BHR’s financial documents, including 2019 company board meeting minutes found on Hunter Biden’s purported laptop and provided to the Washington Examiner by former Steve Bannon War Room podcast co-host Jack Maxey, show the firm had access to tens or hundreds of millions of dollars for Chinese and global investments and purchases, invested in multiple Chinese companies now sanctioned by the United States, and set up a complicated web of China-based and Cayman Island shell companies and subsidiaries.
The Daily Caller noted that “BHR’s business records with NCIPS were updated in April 2020 to reflect Hunter Biden’s departure from its board less than one week after the Daily Caller News Foundationreported that month that his name was still listed as a member of the firm’s board at the time.”
Mesires reached out to the Washington Post a few days after the April 2020 article was published, with Glenn Kessler sharing a letter from BHR’s CEO Jonathan Li, which said : “Mr. Robert Hunter Biden no longer serves as an unpaid director on the board of Bohai Harvest RST (Shanghai) Equity Investment Fund Management Co., Ltd. effective from October 2019.”
Yet, it appears that Hunter Biden still has a substantial financial stake in the Chinese company. BHR and Mesires did not respond to the Washington Examiner’s questions about whether Hunter Biden would relinquish his holdings in the Chinese firm.
Mesires wrote a lengthy post on Medium in mid-October 2019, claiming that Hunter Biden “neither played a role in the formation or licensure of” BHR “nor owned any equity in it while his father was Vice President.” Hunter Biden’s lawyer said his client “served only as a member of its board of directors, which he joined based on his interest in seeking ways to bring Chinese capital to international markets” and that “it was an unpaid position.”
“BHR was capitalized with 30 million renminbi (RMB), or approximately $4.2 million USD at today’s currency exchange rates,” Mesires said. “In October 2017, Hunter committed to invest approximately $420,000 USD (as of 10/12/2019) to acquire a 10% equity position in BHR, which he still holds. To date, Hunter has not received any compensation for being on BHR’s board of directors.”
BHR’s website lists an office in Beijing and brags that the company “is the designated cross-border investment platform of Bohai Industrial Investment Fund and benefits from the support of its Chinese stakeholders including the Bank of China and China Development Bank Capital” and that it “collaborates with Chinese companies in overseas mergers and acquisitions in the high-end manufacturing, healthcare, artificial intelligence and natural resources sectors.”>>
WHAT WASHINGTON EXAMINER MISSED OUT: WHAT SORT OF BUSINESS BHR ACTUALLY DOES?
Luckily, someone else already did most of the work for us, I had to leave out a lot of speculations and “patriotism” and I cherrypicked just the raw good info, so here are some bits and pieces from mainstream media and a much larger and epic work that covers many concerns, The Devolution Series by Patriot Patel:
On September 23, 2020, Senators Ron Johnson and and Chuck Grassley, the chairmen of the Senate Homeland Security and Governmental Affairs Committee (HSGAC) and the Senate Finance Committee, respectively, released a majority staff report entitled “Hunter Biden, Burisma, and Corruption: The Impact on U.S. Government Policy and Related Concerns.”
Clearly, this financial dealing could be a threat to the National Security of the United States by providing the CCP with the Henniges’ anti-vibration tech. Officials from the Pentagon expressed concern over this fact back in 2011:
BHR plays a larger role to the overall story here. Let’s dig in even further. As of August 30, 2021, one of the companies in BHR’s portfolio is Contemporary Amperex Technology Co., Limited (CATL). (Obviously the deal was closed a while before – S.m)
Do you notice anything interesting regarding CATL’s share price from the past year?
Starting right around November, their share price has nearly tripled. What happened in November? Oh yea, the CCP helped Joe Biden steal an election. It isn’t a surprise that the share price of the “world’s largest maker of electric vehicle batteries” has skyrocketed since Biden was “elected.” Everybody saw this coming due to Biden’s socialist agenda and green initiatives.
Recap:
BHR was formed when Bohai Capital (a Chinese-government-linked firm) merged with Rosemont Seneca Partners (company formed by Hunter Biden and Chris Heinz (John Kerry’s stepson)).
Hunter Biden currently has 10% stake in BHR.
CATL is one of the companies in BHR portfolio.
CATL is the “world’s largest maker of electric vehicle batteries”.
You read that correctly. Before the dust even settled over Afghanistan from Biden’s botched withdrawal, China was already in talks with the Taliban attempting to get their hands on those rare earth elements.
The Biden family is set to personally benefit from China gaining access to Afghanistan’s rare earth elements, and I think the timeline can serve as circumstantial evidence. On July 6, 2021, an article was published in the AP titled “US left Afghan airfield at night, didn’t tell new commander.” Keep the title of that article in mind– the US left Afghanistan without telling the Afghan commander.
So that screenshot above points out that “The U.S. announced Friday that it had completely vacated its biggest airfield in the country.” The “Friday” they are referring to was on July 2nd, 2021; just 4 days following the announcement of the deal between CATL and Tesla which was reported on June 28, 2021.
Biden claims he was handcuffed by the deal Trump made with the Taliban for leaving Afghanistan, but I would like to offer an alternative theory. It looks more and more to me as though once again, Trump set a trap and once again, Biden and the Democrats walked right into it.
“If Joe Biden and the United States were supposedly backing the Afghan government, why didn’t we tell them we were leaving Bagram? The withdrawal has allowed the Taliban to swiftly take over nearly the entire country, the same Taliban Trump made a deal with. I don’t want to speculate but I can assure you, there is more to the Afghanistan story than what we’re being led to believe, and believe Trump set the table for things to happen this way. Biden had the opportunity to handle things the right way, but instead he completely botched it.”, Patriot Patel notes.
“Australia has fallen because they gave up their guns”, patriots say. I can’t even see pitchforks in America, right now. Australia feels more alive and kicking with bare hands, sorry.
To be continued? Our work and existence, as media and people, is funded solely by our most generous supporters. But we’re not really covering our costs so far, and we’re in dire needs to upgrade our equipment, especially for video production. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
Ok, everything they’ve done so far was plain retarded but this is some smart evil scheming. Not really original, they steal merits even from plumbing, but there’s finally some intellectual merits to this plan. Or former plan, because it’s not gonna work that well once everybody finds out.
When I said “real cure”, I have not abandoned the truth that Moronavirus exists only on computers, so it can’t have real cures other than ctrl+del. But SARS-COV-2 manufacturers stole some real symptoms from real viruses and diseases. Most of these are sensitive to a set of chemicals like the ones described below. The fake virus would be much harder to prop without some of these real cases of other diseases. And successes against flu, let’s say, are sold as victories against the monstrous Covidzilla.
Also facts:
Most drugs are just botched lab copies of natural compounds. Pfizer’s “twice-a-day Covid pill” is pretty much the same thing to Ivermectin.
“An In-silico data analysis conducted by Choudhury et al. demonstrated that Ivermectin efficiently utilizes viral spike protein, main protease, replicase, and human TMPRSS2 receptors as the most possible targets for executing its “antiviral efficiency” by disrupting binding. Since Ivermectin exploits protein targets from both, the virus and human, this could be the behind its excellent in vitro efficacy against SARS-CoV-2 “
they used the protease description instead of the name, I wonder if intentionally… SOURCE
We identify hydroxychloroquine, a drug that already has approved uses in pregnancy, as a possible inhibitor of NS2B-NS3 protease by using a Food and Drug Administration-approved drug library, molecular docking, and molecular dynamics simulations. Further, to gain insight into its inhibitory potential toward NS2B-NS3 protease, we performed enzyme kinetic studies, which revealed that hydroxychloroquine inhibits protease activity with an inhibition constant (K i) of 92.34 ± 11.91 µM. Additionally, hydroxychloroquine significantly decreases Zika virus infection in placental cells.
The hypothesized scope for all these drugs and others is protease inhibition.
Our results indicate that boceprevir, ombitasvir, paritaprevir, tipranavir, ivermectin, and micafungin exhibited inhibitory effect towards 3CLpro enzymatic activity. The 100 ns molecular dynamics simulation studies showed that ivermectin may require homodimeric form of 3CLpro enzyme for its inhibitory activity. In summary, these molecules could be useful to develop highly specific therapeutically viable drugs to inhibit the SARS-CoV-2 replication either alone or in combination with drugs specific for other SARS-CoV-2 viral targets.
Pfizer found a slightly different strategy to chemically sabotage the protease, there had to be something different to be able to patent it, but that’s like different knives to cut the same sushi, and the science is in where to cut and how deep. This is the actual breakthrough that Ivermectin inventors got a Nobel for, and Pfizer is just ripping it ready-made and tweaking it. Take this to your fav fucked-checker!
It’s harder to steal an icecream cone from a toddler than to sell poison to grown-ups.
To be continued? Our work and existence, as media and people, is funded solely by our most generous supporters. But we’re not really covering our costs so far, and we’re in dire needs to upgrade our equipment, especially for video production. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
Sometimes my memes are 3D. And you can own them. Or send them to someone. You can even eat some of them. CLICK HERE
Remember the outrage at the recent news that China uses popular pregnancy tests to harvest DNA from around the world? Hardly. You probably remember even less about this story. It has been first revealed by The Intercept in 2016, at the peaks of the Trump hysteria (first edition), so no one paid it any real attention, even though a good chunk of mainstream media picked up on it, I even found it on CBS News. Now we’re in the middle of the Afghanistan ‘debacle’, but I hope some of us learned a few things in the meantime and will receive this as it deserves, because first fires shot landed in no-man’s land and you can bet a finger this business model has since been improved and diversified.
SKINCENTIAL SCIENCES, a company with an innovative line of cosmetic products marketed as a way to erase blemishes and soften skin, has caught the attention of beautybloggers on YouTube, Oprah’s lifestyle magazine, and celebrity skin care professionals. Documents obtained by The Intercept reveal that the firm has also attracted interest and funding from In-Q-Tel, the venture capital arm of the Central Intelligence Agency.
The previously undisclosed relationship with the CIA might come as some surprise to a visitor to the website of Clearista, the main product line of Skincential Sciences, which boasts of a “formula so you can feel confident and beautiful in your skin’s most natural state.”
Though the public-facing side of the company touts a range of skin care products, Skincential Sciences developed a patented technology that removes a thin outer layer of the skin, revealing unique biomarkers that can be used for a variety of diagnostic tests, including DNA collection.
Skincential Science’s noninvasive procedure, described on the Clearista website as “painless,” is said to require only water, a special detergent, and a few brushes against the skin, making it a convenient option for restoring the glow of a youthful complexion — and a novel technique for gathering information about a person’s biochemistry.
A screen grab from the Clearista website.
In-Q-Tel, founded in 1999 by then-CIA Director George Tenet, identifies cutting-edge technology to support the mission of the CIA and other intelligence agencies, and provides venture funding to help grow tech firms to develop those solutions.
“Our company is an outlier for In-Q-Tel,” Russ Lebovitz, the chief executive of Skincential Sciences, said during an interview with The Intercept. He conceded that the relationship might make for “an unusual and interesting story,” but said, “If there’s something beneath the surface, that’s not part of our relationship and I’m not directly aware. They’re interested here in something that can get easy access to biomarkers.”
Still, Lebovitz claimed he has limited knowledge of why In-Q-Tel selected his firm.
“I can’t tell you how everyone works with In-Q-Tel, but they are very interested in doing things that are pure science,” Lebovitz said. The CIA fund approached his company, telling him the fund shares an interest in looking at DNA extraction using the method pioneered by Skincential Sciences, according to Lebovitz.The CIA fund has described human skin as a “unique, underutilized source for sample collection.”
Beyond that, Lebovitz said he was unsure of the intent of the CIA’s use of the technology, but the fund was “specifically interested in the diagnostics, detecting DNA from normal skin.” He added, “There’s no better identifier than DNA, and we know we can pull out DNA.”
Perhaps law enforcement could use the biomarker extraction technique for crime scene identification or could conduct drug tests, Lebovitz suggested.
Carrie A. Sessine, the vice president for external affairs at In-Q-Tel, declined a media interview because “IQT does not participate in media interviews or opportunities.”
(Officials at the venture capital firm have, in fact, given interviews in the past.)
Though In-Q-Tel operates in the open, it has often kept key details of its activities out of public view, beyond required annual reports. After a SecureDrop source told The Intercept about a gathering in San Jose for In-Q-Tel executives and start-up companies backed by the fund, The Intercept attempted to attend, but was denied access.
Skincential Sciences was among several presenting companies.
The shroud of secrecy around In-Q-Tel belies a 17-year effort to build ties between the CIA and the biggest names in Silicon Valley. Gilman Louie, a video game executive known for publishing best-sellers such as Tetris, Falcon, and Civilization II, was brought on as the first chief executive of In-Q-Tel. The popular mapping tool Google Earth was created around technology developed by Keyhole Corp., an In-Q-Tel-backed company that was later acquired by Google.
A graphic from the “IQT Quarterly” summer 2010 issue on the new modalities in sampling and sensing collection.
Graphic: IQT Quarterly
Still, little is publicly revealed about the use of In-Q-Tel-backed ventures and their relevance to the goals of intelligence agencies. Many of the fund’s investments are not publicly revealed. The fund is reviewed by the CIA’s inspector general and reports directly to the Senate Select Committee on Intelligence, which frequently conducts business through classified briefings.
David Petraeus, while serving as the director of the CIA in 2012, remarked, “Our partnership with In-Q-Tel is essential to helping identify and deliver groundbreaking technologies with mission-critical applications to the CIA and to our partner agencies.”
Despite the association with computer and satellite technology, In-Q-Tel also maintains a long-running interest in developing advanced genetic analysis, biological technologies for detection and diagnostics, as well as research into what is known as physiological intelligence, which, in a 2010 article, the fund described as “actionable information about human identity and experience that have always been of interest to the Intelligence Community.”
The article, which is no longer available on the fund’s website but is preserved by a cache hosted by the Internet Archive, argues that advances in medical research into biomarkers can be leveraged by intelligence agencies for a variety of uses, from airport security to next-generation identification tools.
A diagram in the article calls human skin the body’s largest organ and a “unique, underutilized source for sample collection.” The author, Dr. Kevin O’Connell, then a “senior solutions architect” with In-Q-Tel, notes, “The DNA contained in microorganisms in a person’s gut or on a person’s skin may contain sequences that indicate a particular geographical origin.”
A screen grab from the Clearista website describing the resurfacing process of its product.
Image: Clearista.com
In-Q-Tel has invested in several companies working in this realm, in addition to Skincential Sciences. In 2013, In-Q-Tel publicly announced a strategic partnership with Bio-NEMS, a firm that developed a semiconductor device used to analyze DNA for a variety of diagnostic and human identification applications. Claremont BioSolutions, a diagnostics firm, and Biomatrica, a firm that specializes in preparing biological samples for DNA testing, are also backed by In-Q-Tel.
Skincential Sciences did not start out as a beauty company. The firm was founded in 2010 as DX Biosciences, which was developed around a patent by a team of scientists including Dr. Samir Mitragotri of the University of California, Santa Barbara. Mitragotri has published research into the use of biomarkers as a “window to body’s health.”
The company gained early backing from Frontier, a venture capital company, among other investors.
While the technology has potential for a variety of medical diagnostics, including early melanoma detection, Lebovitz said the company quickly realized it had immediate value as a cosmetic. The application of the detergent developed by the firm could be used easily to diminish blemishes and dark patches on the skin. And unlike similar treatments at aesthetic spas, the technology developed by Dr. Mitragotri and his colleagues did not require acid or any discomfort.
In 2013, the firm relaunched and recapitalized as Skincential Sciences, with Clearista as its primary brand of beauty products.
Lebovitz says he intends to continue developing the technology so that it may be medically relevant, but he is also focusing on breaking into the multibillion-dollar skin care market. While Skincential has won measured success for its Clearista brand products by landing coverage on television and through social media, the company has not yet been able to compete with mainstream skin care companies.
Jamie Walsh, a blogger who runs Glam Latte, a beauty website, endorsed a Clearista product on her YouTube channel, noting that with only one application of the cream, her skin improved and was “glowing.” Walsh said Skincential Sciences sent her the product for a testimonial, and noted that like many independent brands, she did not know about the company’s funding.
Skincential hopes to license its product with a major distributor, or even one day become acquired by a larger beauty company. “We’ll take any of those,” said Lebovitz.
The chief executive noted that he is proud of the In-Q-Tel support, calling the fund “great partners.”
At the gathering in February for In-Q-Tel portfolio companies, Lebovitz joined a crowd that included a number of In-Q-Tel executives, along with senior members of the intelligence community. Presenting speakers included Federal Bureau of Investigation Director James Comey, Deputy Secretary of Defense Robert Work, and John Maeda, design partner of Kleiner Perkins Caufield & Byers, a leading Silicon Valley investment firm.
“Not only was I the odd man out,” Lebovitz said, “but almost every woman at the conference wanted to come up to me to talk about skin care. – The Intercept
To be continued? Our work and existence, as media and people, is funded solely by our most generous supporters. But we’re not really covering our costs so far, and we’re in dire needs to upgrade our equipment, especially for video production. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
So, is this the world you guys plan to live in? Nazis are babies next to covidiots and you might be next in line. Not to have my fate, but to have this poor man’s fate…
Poor people get ‘terminated’ by medical assassins, then their partners in crime terminate any witnesses and whistleblowers. This seems to be the new business and social model. Our site is crippled again because YouTube terminated our second channel, without any possibility of appeal or anything. Ten minutes after the upload it was down. Just please watch the 100 seconds that triggered the Googlag mass-murderers so much and think for yourself!
Sorry for the site being incomplete again, we’re too poor to afford enough server space and our host, WordPress, only embeds censored platforms, but most articles should hold even without the video support. Most videos are already backed up on Odysee, Brighteon and Bitchute, I just can’t embed them here. We’re not done, just a bit hurt, but we’re exhausted of energy and resources, a lot is going out, very little coming in. Most exhausting is, though, watching people still feeding and collaborating with their Nemesis.
I still have some scattered back-ups and I’m going to make more and keep red-pilling YouTubers. Help, if you will, preaching only to the choir is not that efficient.
To be continued? Our work and existence, as media and people, is funded solely by our most generous supporters. But we’re not really covering our costs so far, and we’re in dire needs to upgrade our equipment, especially for video production. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
We gave up on our profit shares from masks, if you want to help us, please use the donation button! We think frequent mask use, even short term use can be bad for you, but if you have no way around them, at least send a message of consciousness. Get it here!
To be continued? Our work and existence, as media and people, is funded solely by our most generous supporters. But we’re not really covering our costs so far, and we’re in dire needs to upgrade our equipment, especially for video production. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
There are several storylines that are likely to reach a peak or a turning point around December 2021:
The Covid narrative hardly holds. And by December the body count will be so high many vaccinated people will find it hard to ignore. When vaccine survivors realize what’s up, it’s going to be extremely hard to contain social unrest without mass violence.
The Petrodollar hardly holds. Especially after the Afghanistan crisis.
The US hardly holds. The situation is very similar to USSR’s after the Afghanistan pull out, having the same money, schemes and actors attacking US, just this time they are much more experienced, equipped and infiltrated in a more feeble enemy camp. It took Soros and the Funky Bunch about two more years after Afghanistan to see USSR off the maps, he might need only about three months now. The only plus on the US side is much more awareness and preparedness among the general population, and that needs to increase rapidly. The fall of USSR and the Berlin Wall caught people there very unaware, unprepared and psychologically vulnerable and that felt. I know because I was a teenager in communist Romania at the time.
Free Internet hardly holds. Klaus Schwab is desperate to take out the last bastions of free speech left on Internet before they take him out, and his Cyberpolygon threats disguised as warnings will materialize any soon in some digital false flag.
The supply chains hardly hold. The attack is from inside this time, but nutters don’t seem to understand people react much more violently when you threaten their food than when you attack their freedom. For obvious reasons. Or maybe they do get it and already have a defense in place, more likely. Either way, if they keep at it much longer, this will blow with a big Bang.
The Epstein story has very explosive potential too, and there are many more landmines waiting to blow up that I didn’t mention here.
Dark Winter Biodefense Drill Official Trailer / Blames Irak just like Colin Powell later (2001)
The psychos running the show are, of course, readying their own preparedness for this, what they do in Australia or Canada is just exercises for containing civil disobedience, health is a pathetic attempt at excusing that totalitarianism. Of course there are much more variables and some of them have the power to turn things around to a certain degree, but the chances to avoid something really drastic this winter are nearing zero when they tell you about it since summer.
UPDATE September 3, 2021:
In the past three days I’ve hear of attacks on Covid establishments in Australia and Spain, very sketchy stuff like the reports of burning 5G towers that disappeared immediately, in sync, when the agenda shifted.
To be continued? Our work and existence, as media and people, is funded solely by our most generous supporters. But we’re not really covering our costs so far, and we’re in dire needs to upgrade our equipment, especially for video production. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
Did you even know that PCRs are used under the EUA too? I called this a ‘PCRdemic’ in a meme last year and I’ve been proven right countless times.
A blast from a past pandemic
Let’s play dumb for a moment and pretend we believe SARS-COV-2 exists outside computers and human minds.
All Covid vaccine trials have shown is infinitesimally tiny decreases in symptoms for injected fools. To detect these tiny differences, they used the largely erroneous and unreliable non-tests known as PCR. (They also ‘morphed’ some symptoms into adverse effects to get the needed numbers, but that’s another story). If you can’t defend PCR tests, you can’t defend Covid injections. And anyone with at least half a functional brain knows there’s nothing to defend, because there’s no such this as PCR Covid tests, there may be PCRs and SARS-COV-2 tests, as separate items only. So these Covid injections trials and studies are worth precisely and exactly: NOTHING. They are as null as all Covid stats, the whole Covid sham and anything based on PCRs as a diagnose tool or as a quantitative detector. All approvals based on these trials and studies are null. Up until today, officials have maintained that PCRs are “the gold-standard of Covid testing”, so it’s not wrong to extrapolate their accuracy to the whole Covidiocracy.
“According to a Johns Hopkins study, this so-called gold standard RT-PCR test can have a false negative up to 20 to 66 percent of the time in even symptomatic patients depending upon the test’s timing. False negatives can be up to 100 percent on day one of exposure (asymptomatic) and down to 20 percent on day 8 of exposure (day 3 of symptoms) and then starts going up again. Statistics tell us that the false-negative rate goes up even higher as the prevalence of disease goes up, as is the case with COVID right now. A meta-analysis from Europe actually found an average false negative of 54 percent. These numbers are actually from monitored and regulated studies where things are done more meticulously than real-world scenarios. Performing many of these tests quickly in the clinical setting because of soaring demand, with each test resulting in sampling error, pressure on labs to provide quick turnaround, and rationing of scarce reagents in labs increase this percentage even higher. Some mutations could be potentially affecting the accuracy as well.” – KevinMD “Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.“
I say flipping the coin would achieve similar results as PCRs, I dare everyone to test this. But even if its error margin was only about 8%, as Mayo Clinic claims, that’s still eight times bigger than the variations detected in Pfizer’s or Moderna’s lab humans. Fact-check this! Plenty more resources on this very website and its extensions. If self-evidence and logic are not your thing, I have two guys here who seem to agree, they’re kinda advised in this field:
Now, just to flex a bit, allow me to fact-check the fact-checker that made even NYT to retract one of their best and most honest articles since Covid, claiming as much as 90% of PCR positives may be false.
Healthfeedback.org claims ultrasensitivity in tests doesn’t matter because PCRs are not used quantitatively, just to detect presence, as they should. They admit that people who are not sick or not even infectious, people who were sick in the past (but not anymore) and people who might be sick in the future (but not yet), are considered cases, just because the tiniest viral load is detected:
Some outlets have even called these high Ct positive results “false positives”, which is inaccurate. The term “false positive” indicates that a person tested positive but does not have the disease[1]. However, the New York Times report makes it clear that a person is or has been infected if they test positive, regardless of whether the test had a high or low Ct value. This also means that it is appropriate to consider a person with a positive result and high Ct value as a COVID-19 case. Therefore, the sensitivity of the PCR test is not responsible for the high number of cases in the U.S. Simply put, case numbers are high because there are many infected people. This indicates a high level of virus transmission in the community and public health measures, such as physical distancing and lockdowns, are effective and important for reducing the number of infections and protecting the community[2,3]. Apoorva Mandavilli, the journalist who wrote the New York Times article, also stressed this point in a Twitter thread, clarifying that “people who test positive but with high CTs *were* contagious, just at an earlier time point. They are not contagious *anymore*. Doesn’t mean they were never infected, so doesn’t affect the case count.”
As they accuse NYT of using straw man arguments, fact-checkers do precisely that, as per usual. We, the independent scholars and media, were the first to cry out PCRs are not a quantitative tool, the establishment never bothered to educate, we dug out PCR inventor Kari Mullis’ teachings, as early as last summer. So we are more aware even than NYT presstitutes, vocational press-release copy-pasters, and when we accuse hypersensitivity in tests, it’s mainly about QUALITATIVE sensitivity. What happens if a tiny viral fragment detected is MISIDENTIFIED, not just misquantized, because hypersensitivity or overcycling?
WHO already admitted it, the numbers of amplification cycles influence the qualitative sensitivity, that’s why they lowered the threshold on Biden’s inauguration day: this trash was detecting anything and everything the way it was used.
What happens if the test reacts to something we all normally live with, since our virome is comprised of countless millions of varieties and we’re also full of viral debris? Don’t you get the perfect pandemic? Besides toasting bread and burping, is there anything simpler to achieve? How else would you get dozens of labs sending 100% positives like they did last year?! IMPOSSIBLE, YET OFFICIAL: 100% POSITIVE CORONAVIRUS TESTS RESULTS FROM OVER 30 LABS IN FLORIDA, ON JULY 11TH 2020
Prof. David Rasnick PhD is a reputed researcher, a friend of Kari Mullis’ and one of the first to whistleblow on the AIDS hoax. A bit of a hero to me
Now back to vaccine trials: They can’t afford lumping together past, present and potential future sick people, as PCRs do, the trials are supposed to measure present symptoms in currently ill people, past and future are beyond the scope. To these trials, the quantitative aspect is crucially relevant, because it’s different in each category. I hope it goes without saying that the correct identification of the virus is paramount, and, as the PCR inventor put it: “These things can find anything if you keep cycling”. So, top authoritative sources, logic and life experience confirm:
PCRs need to be backed by proper lab analysis, they mean nothing by themselves.
Why do you think they burn bodies without autopsy? At the coroner is where the real testing happens, so they illegally destroy murder evidence.
LATER UPDATE: TOP SHELF AUTHORITATIVE SOURCE ENDS THE DEBATE
I know, we need to enlarge our horizons, and by a lot, just to encompass how big the scam is… almost as large as the mass-mental-retardation pandemic sweeping the species with infinitely more casualties than any natural virus. I know, it may be hard to flex that much, makes anyone dizzy, but if we’re not capable of doing it quickly and at mass-level, we are going to have a mass-level extinction instead. But I also know I’d rather live to see a crowd-sourced investigation into Kari Mullis’ suspicious death just months ahead of the pandemic. It’s doable if we flex our horizon and brain more and more often.
It’s gonna be a Very Dark Winter and we need ‘flexi-brains’ to come out of it, among other skills.
To be continued? Our work and existence, as media and people, is funded solely by our most generous supporters. But we’re not really covering our costs so far, and we’re in dire needs to upgrade our equipment, especially for video production. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
You can’t have a single product with two commercial names in the same place, at the same time. BionTech hasn’t been erased. So there are two Pfizer products: Comirnaty and Pfizer-BionTech.
Until the vial content is independently audited, we can’t know the difference between the two, because this info has been redacted from the publicly available letters. But we know for sure there is one and it’s significant enough to earn a new commercial name.
(After four updates that I had to erase to clarify and make this more readable)
“BioNTech said it was developing four vaccine candidates under a programme named BNT162 with its partner, pharma giant Pfizer… BioNTech, which awarded the rights in China to BNT162 to Shanghai Fosun Pharmaceutical under a March collaboration deal…” – Reuters
In its press release, Pfizer maintains: “The FDA-approved COMIRNATY® (COVID-19 Vaccine, mRNA) and the EUA-authorized Pfizer-BioNTech COVID-19 Vaccine have the same formulation and can be used interchangeably to provide the COVID-19 vaccination series. An individual may be offered either COMIRNATY® (COVID-19 Vaccine, mRNA) or the Pfizer-BioNTech COVID-19 Vaccine to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2.”
In the same press release, we find out the Comirnaty concoct is scientifically identified as BNT162b2. Like the afore-mentioned program BNT162, version ‘b2’. It’s the same one as in the US EUA, so, officially, the EUA and the full approval (BLA) are awarded to the same formulation indeed, we can get that out of the way.
However, the European EUA doesn’t mention any of the formulation, so we cannot know what they used there. A German government website does mention b2, EMA (the European FDA) doesn’t anywhere, or I haven’t found it yet.
And when you think “this is it”, it’s never it: Looks like FDA itself picked b2 and knew the trial data is mixed up between formulations, had no problem with it, more so, I discovered there were even more versions used in trials, such as b3c and so forth. Don’t believe me, check page 15 in this FDA document (PDF), as pictured at the top of the article!
One question remains: Comirnaty as commercial name has long been used in EU, maybe not much in ads or mainstream media for decerebrated plebs, but in anything more technical than that. Why not in US, if they used the same formulation? Symmetrically, EU used the name, but no so sure about the b2 formulation.
And after all this, no one can be certain what formulation they actually put in the vials.
In a sane world, the Pfizer approval blunder would be the medical equivalent of the Afghanistan ‘blunder’. Forget about informed consent, safety, data… all they have is more guns. Which brings me to…
The US Government, like most others, has left legality in March 2020 and not governing. There are dozens of known old meds that can treat these respiratory problems labeled as Covid, more are screened and discovered, there was no evidence of a new virus, at least at the time when they introduced the Emergency state. So the Emergency, the government instating it and everything that started with it is illegal and an act of terrorism. So US doesn’t have a government, but a terrorist organization holding it hostage. Nothing they did after March 2020 is remotely legal, both Trump and Biden should stand in the accused box at Nuremberg 2 now. But sleepy ghosts are changing bed sides dreaming they wake up as people who still hold a little control over their lives. In fact, all this is held together solely by the gun, military superiority, and psychological abuse, legal talk is 200% off and it’s just deepening the mass-hypnosis. There is no law but the gun, if the government didn’t have a laser point on each forehead, it wouldn’t even exist at this point. It’s bare war. If you’re not ready to internalize reality, you are not ready to change it.
Going to say this again: If #FDA officials like Gruber walk away from adcomms just deciding in their own minds what they heard & not what was actually said, what's the point?
<<Two of the U.S. Food and Drug Administration’s (FDA) top vaccine regulators will leave the agency this fall, raising questions about the Biden administration and the way it sidelined the agency.
According to an email sent by Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research (CBER), to staff members Tuesday, Dr. Marion Gruber, director of the FDA’s vaccines office, will quit at the end of October, and her deputy, Dr. Philip Krause, will leave in November.
Gruber and Krause were upset about the Biden administration’s recent announcement that adults should get a COVID booster eight months after they received a second shot, people familiar with the decision told The New York Times.
Neither believed there was enough data to justify offering booster shots yet, the sources said, and both viewed the announcement, amplified by President Biden, as pressure on the FDA to quickly authorize them.
Marks said he would serve as the acting director of the vaccines office while the agency searched for its next leader.
FDA Spokeswoman Stephanie Caccomo said the agency was “confident in the expertise and ability of our staff to continue our critical public health work.”
However, a former senior FDA leader told Endpoints News, Gruber and Krause are departing because they’re frustrated the Centers for Disease Control and Prevention (CDC) and its advisory panel — the Advisory Committee on Immunizations and Practices (ACIP) — are involved in decisions they think should be up to the FDA.
The source said he heard Gruber and Krause were upset with Marks for not insisting those decisions be kept inside the FDA, and with the White House for getting ahead of FDA on booster shots.
“These two are the leaders for biologic [vaccine] review in the U.S.,” wrote Rick Bright, former director of the Biomedical Advanced Research and Development Authority, weighing in on the news. “They have a great team, but these two are the true leaders of CBER. A huge global loss if they both leave,” Bright said.
“Dr. Gruber is much more than the director,” Bright added. “She is a global leader. Visionary mastermind behind global clinical regulatory science for flu, Ebola, Mers, Zika, Sars-CoV-2, many others.”>>
Anyone who thinks she sweated harder than Trump for Pfizer’s approval, but all of a sudden had a change of mind and decided to sabotage the boosters is a baby. She’s hiding from justice.
I made this in June 2020. The Grubers are many.
I hope this helped, if anything, I’ll add it here.
To be continued? Our work and existence, as media and people, is funded solely by our most generous supporters. But we’re not really covering our costs so far, and we’re in dire needs to upgrade our equipment, especially for video production. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
To be continued? Our work and existence, as media and people, is funded solely by our most generous supporters. But we’re not really covering our costs so far, and we’re in dire needs to upgrade our equipment, especially for video production. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
We need to speed up our little awakening because we’re still light-years behind the reality. This dwarfs Afghanistan and Covid is but a chapter in its playbook. This connects all the trigger-words: 5G, Covid, Vaccines, Graphene, The Great Reset, Blockchain, The Fourth Industrial Revolution and beyond.
A wide variety of internet-connected “smart” devices now promise consumers and businesses improved performance, convenience, efficiency, and fun. Within this broader Internet of Things (IoT) lies a growing industry of devices that monitor the human body, collect health and other personal information, and transmit that data over the internet. We refer to these emerging technologies and the data they collect as the Internet of Bodies (IoB) (see, for example, Neal, 2014; Lee, 2018), a term first applied to law and policy in 2016 by law and engineering professor Andrea M. Matwyshyn (Atlantic Council, 2017; Matwyshyn, 2016; Matwyshyn, 2018; Matawyshyn, 2019). IoB devices come in many forms. Some are already in wide use, such as wristwatch fitness monitors or pacemakers that transmit data about a patient’s heart directly to a cardiologist. Other products that are under development or newly on the market may be less familiar, such as ingestible products that collect and send information on a person’s gut, microchip implants, brain stimulation devices, and internet-connected toilets. These devices have intimate access to the body and collect vast quantities of personal biometric data. IoB device makers promise to deliver substantial health and other benefits but also pose serious risks, including risks of hacking, privacy infringements, or malfunction. Some devices, such as a reliable artificial pancreas for diabetics, could revolutionize the treatment of disease, while others could merely inflate health-care costs with little positive effect on outcomes. Access to huge torrents of live-streaming biometric data might trigger breakthroughs in medical knowledge or behavioral understanding. It might increase health outcome disparities, where only people with financial means have access to any of these benefits. Or it might enable a surveillance state of unprecedented intrusion and consequence. There is no universally accepted definition of the IoB. For the purposes of this report, we refer to the IoB, or the IoB ecosystem, as IoB devices (defined next, with further explanation in the passages that follow) together with the software they contain and the data they collect.
An IoB device is defined as a device that • contains software or computing capabilities • can communicate with an internet-connected device or network and satisfies one or both of the following: • collects person-generated health or biometric data • can alter the human body’s function. The software or computing capabilities in an IoB device may be as simple as a few lines of code used to configure a radio frequency identification (RFID) microchip implant, or as complex as a computer that processes artificial intelligence (AI) and machine learning algorithms. A connection to the internet through cellular or Wi-Fi networks is required but need not be a direct connection. For example, a device may be connected via Bluetooth to a smartphone or USB device that communicates with an internet-connected computer. Person-generated health data (PGHD) refers to health, clinical, or wellness data collected by technologies to be recorded or analyzed by the user or another person. Biometric or behavioral data refers to measurements of unique physical or behavioral properties about a person. Finally, an alteration to the body’s function refers to an augmentation or modification of how the user’s body performs, such as a change in cognitive enhancement and memory improvement provided by a brain-computer interface, or the ability to record whatever the user sees through an intraocular lens with a camera. IoB devices generally, but not always, require a physical connection to the body (e.g., they are worn, ingested, implanted, or otherwise attached to or embedded in the body, temporarily or permanently). Many IoB devices are medical devices regulated by the U.S. Food and Drug Administration (FDA).3 Figure 1 depicts examples of technologies in the IoB ecosystem that are either already available on the U.S. market or are under development. Devices that are not connected to the internet, such as ordinary heart monitors or medical ID bracelets, are not included in the definition of IoB. Nor are implanted magnets (a niche consumer product used by those in the so-called bodyhacker community described in the next section) that are not connected to smartphone applications (apps), because although they change the body’s functionality by allowing the user to sense electromagnetic vibrations, the devices do not contain software. Trends in IoB technologies and additional examples are further discussed in the next section. Some IoB devices may fall in and out of our definition at different times. For example, a Wi-Fi-connected smartphone on its own would not be part of the IoB; however, once a health app is installed that requires connection to the body to track user information, such as heart rate or number of steps taken, the phone would be considered IoB. Our definition is meant to capture rapidly evolving technologies that have the potential to bring about the various risks and benefits that are discussed in this report. We focused on analyzing existing and emerging IoB technologies that appear to have the potential to improve health and medical outcomes, efficiency, and human function or performance, but that could also endanger users’ legal, ethical, and privacy rights or present personal or national security risks. For this research, we conducted an extensive literature review and interviewed security experts, technology developers, and IoB advocates to understand anticipated risks and benefits. We had valuable discussions with experts at BDYHAX 2019, an annual convention for bodyhackers, in February 2019, and DEFCON 27, one of the world’s largest hacker conferences, in August 2019. In this report, we discuss trends in the technology landscape and outline the benefits and risks to the user and other stakeholders. We present the current state of governance that applies to IoB devices and the data they collect and conclude by offering recommendations for improved regulation to best balance those risks and rewards.
The IoB is related to several movements outside of formal health care focused on integrating human bodies with technology. Next, we summarize some of these concepts, though there is much overlap and interchangeability among them. Transhumanism is a worldview and political movement advocating for the transcendence of humanity beyond current human capabilities. Transhumanists want to use technology, such as artificial organs and other techniques, to halt aging and achieve “radical life extension” (Vita-Moore, 2018). Transhumanists may also seek to resist disease, enhance their intelligence, or thwart fatigue through diet, exercise, supplements, relaxation techniques, or nootropics (substances that may improve cognitive function). Bodyhackers, biohackers, and cyborgs, who enjoy experimenting with body enhancement, often refer to themselves as grinders. They may or may not identify as transhumanists. These terms are often interchanged in common usage, but some do distinguish between them (Trammell, 2015). Bodyhacking generally refers to modifying the body to enhance one’s physical or cognitive abilities. Some bodyhacking is purely aesthetic. Hackers have implanted horns in their heads and LED lights under their skin. Other hacks, such as implanting RFID microchips in one’s hand, are meant to enhance function, allowing users to unlock doors, ride public transportation, store emergency contact information, or make purchases with the sweep of an arm (Baenen, 2017; Savage, 2018). One bodyhacker removed the RFID microchip from her car’s key fob and had it implanted in her arm (Linder, 2019). A few bodyhackers have implanted a device that is a combined wireless router and hard drive that can be used as a node in a wireless mesh network (Oberhaus, 2019). Some bodyhacking is medical in nature, including 3D-printed prosthetics and do-it-yourself artificial pancreases. Still others use the term for any method of improving health, including bodybuilding, diet, or exercise. Biohacking generally denotes techniques that modify the biological systems of humans or other living organisms. This ranges from bodybuilding and nootropics to developing cures for diseases via self-experimentation to human genetic manipulation through CRISPR-Cas9 techniques (Samuel, 2019; Griffin, 2018). Cyborgs, or cybernetic organisms, are people who have used machines to enhance intelligence or the senses. Neil Harbisson, a colorblind man who can “hear” color through an antenna implanted in his head that plays a tune for different colors or wavelengths of light, is acknowledged as the first person to be legally recognized by a government as a cyborg, by being allowed to have his passport picture include his implant (Donahue, 2017). Because IoB is a wide-ranging field that intersects with do-it-yourself body modification, consumer products, and medical care, understanding its benefits and risks is critical.
The Internet of Bodies is here. This is how it could change our lives
04 Jun 2020, Xiao Liu Fellow at the Centre for the Fourth Industrial Revolution, World Economic Forum
We’re entering the era of the “Internet of Bodies”: collecting our physical data via a range of devices that can be implanted, swallowed or worn.
The result is a huge amount of health-related data that could improve human wellbeing around the world, and prove crucial in fighting the COVID-19 pandemic.
But a number of risks and challenges must be addressed to realize the potential of this technology, from privacy issues to practical hurdles.
In the special wards of Shanghai’s Public Health Clinical Center, nurses use smart thermometers to check the temperatures of COVID-19 patients. Each person’s temperature is recorded with a sensor, reducing the risk of infection through contact, and the data is sent to an observation dashboard. An abnormal result triggers an alert to medical staff, who can then intervene promptly. The gathered data also allows medics to analyse trends over time.
The smart thermometers are designed by VivaLNK, a Silicon-Valley based startup, and are a powerful example of the many digital products and services that are revolutionizing healthcare. After the Internet of Things, which transformed the way we live, travel and work by connecting everyday objects to the Internet, it’s now time for the Internet of Bodies. This means collecting our physical data via devices that can be implanted, swallowed or simply worn, generating huge amounts of health-related information.
Some of these solutions, such as fitness trackers, are an extension of the Internet of Things. But because the Internet of Bodies centres on the human body and health, it also raises its own specific set of opportunities and challenges, from privacy issues to legal and ethical questions.
Image: McKinsey & Company
Connecting our bodies
As futuristic as the Internet of Bodies may seem, many people are already connected to it through wearable devices. The smartwatch segment alone has grown into a $13 billion market by 2018, and is projected to increase another 32% to $18 billion by 2021. Smart toothbrushes and even hairbrushes can also let people track patterns in their personal care and behaviour.
For health professionals, the Internet of Bodies opens the gate to a new era of effective monitoring and treatment.
In 2017, the U.S. Federal Drug Administration approved the first use of digital pills in the United States. Digital pills contain tiny, ingestible sensors, as well as medicine. Once swallowed, the sensor is activated in the patient’s stomach and transmits data to their smartphone or other devices.
In 2018, Kaiser Permanente, a healthcare provider in California, started a virtual rehab program for patients recovering from heart attacks. The patients shared their data with their care providers through a smartwatch, allowing for better monitoring and a closer, more continuous relationship between patient and doctor. Thanks to this innovation, the completion rate of the rehab program rose from less than 50% to 87%, accompanied by a fall in the readmission rate and programme cost.
The deluge of data collected through such technologies is advancing our understanding of how human behaviour, lifestyle and environmental conditions affect our health. It has also expanded the notion of healthcare beyond the hospital or surgery and into everyday life. This could prove crucial in fighting the coronavirus pandemic. Keeping track of symptoms could help us stop the spread of infection, and quickly detect new cases. Researchers are investigating whether data gathered from smartwatches and similar devices can be used as viral infection alerts by tracking the user’s heart rate and breathing.
At the same time, this complex and evolving technology raises new regulatory challenges.
What counts as health information?
In most countries, strict regulations exist around personal health information such as medical records and blood or tissue samples. However, these conventional regulations often fail to cover the new kind of health data generated through the Internet of Bodies, and the entities gathering and processing this data.
In the United States, the 1996 Health Insurance Portability and Accountability Act (HIPPA), which is the major law for health data regulation, applies only to medical providers, health insurers, and their business associations. Its definition of “personal health information” covers only the data held by these entities. This definition is turning out to be inadequate for the era of the Internet of Bodies. Tech companies are now also offering health-related products and services, and gathering data. Margaret Riley, a professor of health law at the University of Virginia, pointed out to me in an interview that HIPPA does not cover the masses of data from consumer wearables, for example.
Another problem is that the current regulations only look at whether the data is sensitive in itself, not whether it can be used to generate sensitive information. For example, the result of a blood test in a hospital will generally be classified as sensitive data, because it reveals private information about your personal health. But today, all sorts of seemingly non-sensitive data can also be used to draw inferences about your health, through data analytics. Glenn Cohen, a professor at Harvard Law school, told me in an interview that even data that is not about health at all, such as grocery shopping lists, can be used for such inferences. As a result, conventional regulations may fail to cover data that is sensitive and private, simply because it did not look sensitive before it was processed.
Data risks
Identifying and protecting sensitive data matters, because it can directly affect how we are treated by institutions and other people. With big data analytics, countless day-to-day actions and decisions can ultimately feed into our health profile, which may be created and maintained not just by traditional healthcare providers, but also by tech companies or other entities. Without appropriate laws and regulations, it could also be sold. At the same time, data from the Internet of Bodies can be used to make predictions and inferences that could affect a person’s or group’s access to resources such as healthcare, insurance and employment.
James Dempsey, director of the Berkeley Center for Law and Technology, told me in an interview that this could lead to unfair treatment. He warned of potential discrimination and bias when such data is used for decisions in insurance and employment. The affected people may not even be aware of this.
One solution would be to update the regulations. Sandra Wachter and Brent Mittelstadt, two scholars at the Oxford Internet Institute, suggest that data protection law should focus more on how and why data is processed, and not just on its raw state. They argue for a so-called “right to reasonable inferences”, meaning the right to have your data used only for reasonable, socially acceptable inferences. This would involve setting standards on whether and when inferring certain information from a person’s data, including the state of their present or future health, is socially acceptable or overly invasive.
Practical problems
Apart from the concerns over privacy and sensitivity, there are also a number of practical problems in dealing with the sheer volume of data generated by the Internet of Bodies. The lack of standards around security and data processing makes it difficult to combine data from diverse sources, and use it to advance research. Different countries and institutions are trying to jointly overcome this problem. The Institute of Electrical and Electronics Engineers (IEEE) and its Standards Association have been working with the US Food & Drug Administration (FDA), National Institutes of Health, as well as universities and businesses among other stakeholders since 2016, to address the security and interoperability issue of connected health.
As the Internet of Bodies spreads into every aspect of our existence, we are facing a range of new challenges. But we also have an unprecedented chance to improve our health and well-being, and save countless lives. During the COVID-19 crisis, using this opportunity and finding solutions to the challenges is a more urgent task than ever. This relies on government agencies and legislative bodies working with the private sector and civil society to create a robust governance framework, and to include inferences in the realm of data protection. Devising technological and regulatory standards for interoperability and security would also be crucial to unleashing the power of the newly available data. The key is to collaborate across borders and sectors to fully realize the enormous benefits of this rapidly advancing technology.
Governance of IoB devices is managed through a patchwork of state and federal agencies, nonprofit organizations, and consumer advocacy groups
The primary entities responsible for governance of IoB devices are the FDA and the U.S. Department of Commerce.
Although the FDA is making strides in cybersecurity of medical devices, many IoB devices, especially those available for consumer use, do not fall under FDA jurisdiction.
Federal and state officials have begun to address cybersecurity risks associated with IoB that are beyond FDA oversight, but there are few laws that mandate cybersecurity best practices.
As with IoB devices, there is no single entity that provides oversight to IoB data
Protection of medical information is regulated at the federal level, in part, by HIPAA.
The Federal Trade Commission (FTC) helps ensure data security and consumer privacy through legal actions brought by the Bureau of Consumer Protection.
Data brokers are largely unregulated, but some legal experts are calling for policies to protect consumers.
As the United States has no federal data privacy law, states have introduced a patchwork of laws and regulations that apply to residents’ personal data, some of which includes IoB-related information.
The lack of consistency in IoB laws among states and between the state and federal level potentially enables regulatory gaps and enforcement challenges.
Recommendations
The U.S. Commerce Department can put foreign IoB companies on its “Entity List,” preventing them from doing business with Americans, if those foreign companies are implicated in human rights violations.
As 5G, Wi-Fi 6, and satellite internet standards are rolled out, the federal government should be prepared for issues by funding studies and working with experts to develop security regulations.
It will be important to consider how to incentivize quicker phase-out of the legacy medical devices with poor cybersecurity that are already in wide use.
IoB developers must be more attentive to cybersecurity by integrating cybersecurity and privacy considerations from the beginning of product development.
Device makers should test software for vulnerabilities often and devise methods for users to patch software.
Congress should consider establishing federal data transparency and protection standards for data that are collected from the IoB.
The FTC could play a larger role to ensure that marketing claims about improved well-being or specific health treatment are backed by appropriate evidence.
JAMMU and Kashmir is almost always in the news for one reason or another. Apart from the obvious political headlines, J&K was also in the news because of covid-19. As the world struggled with covid-19 pandemic, J&K faced a peculiar situation due to its poor health infrastructure. Nonetheless, all sections of society did a commendable job in keeping covid under control and preventing the loss of life as much as possible. The doctors Association in Kashmir along with the administration did as much as possible through their efforts. For that we are all thankful to them. However, it is about time that we integrate our Healthcare System by upgrading it and introducing to it new technologies from the current world.
We’ve all heard of the Internet of Things, a network of products ranging from refrigerators to cars to industrial control systems that are connected to the internet. Internet of Bodies (IoB) the outcome of the Internet of Things (IoT) is broadly helping the healthcare system and every individual to live life with ease by managing the human body in terms of technology. The Internet of Bodies connects the human body to a network of internet run devices.
The use of IoB can be independent or by the health care heroes (doctors) to monitor, report and enhance the health system of the human body. The internet of Bodies (IoB) are broadly classified into three categories or in some cases we can say three generations – Body Internal, Body External and Body embedded. The Body Internal model of IoB is the category, in which the individual or patient is interacting with the technology environment or we can say internet or our healthcare system by having an installed device inside the human body. Body External model or generation of IoB signifies the model where the device is installed external to the body for certain usage viz. Apple watches and other smart bands from various OEM’s for tracking blood pressure, heart rate etc which can later be used for proper health tracking and monitoring purposes. Last one under this classifications are Body Embedded, in which the devices are embedded under the skin by health care professionals during a number of health situations.
The Internet of Bodies is a small part or even the offspring of the Internet of Things. Much like it, there remains the challenge of data and information breach as we have already witnessed many excessive distributed denial of service (DDos) attacks and other cyber-attacks on IoTs to exploit data and gather information. The effects are even more severe and vulnerable in the case of the Internet of Bodies as the human body is involved in this schema.
The risk of these threats has taken over the discussion about the IOBs. Thus, this has become a great concern in medical technology companies. Most of the existing IoB companies just rely on end-user license agreements and privacy policies to retain rights in software and to create rights to monitor, aggregate and share users’ body data. They just need to properly enhance the security model and implement high security measures to avoid any misfortune. For the same the Government of India is already examining the personal data protection bill 2019.
The Internet has not managed to change our lifestyles in the way the internet of things will!
Views expressed in the article are the author’s own and do not necessarily represent the editorial stance of Kashmir Observer
The author is presently Manager IT & Ops In HK Group
Social media, sensor feeds, and scientific studies generate large amounts of valuable data. However, understanding the relationships among this data can be challenging. Graph analytics has emerged as an approach by which analysts can efficiently examine the structure of the large networks produced from these data sources and draw conclusions from the observed patterns. By understanding the complex relationships both within and between data sources, a more complete picture of the analysis problem can be understood. With lessons learned from innovations in the expanding realm of deep neural networks, the Hierarchical Identify Verify Exploit (HIVE) program seeks to advance the arena of graph analytics.
The HIVE program is looking to build a graph analytics processor that can process streaming graphs 1000X faster and at much lower power than current processing technology. If successful, the program will enable graph analytics techniques powerful enough to solve tough challenges in cyber security, infrastructure monitoring and other areas of national interest. Graph analytic processing that currently requires racks of servers could become practical in tactical situations to support front-line decision making. What ’s more, these advanced graph analytics servers could have the power to analyze the billion- and trillion-edge graphs that will be generated by the Internet of Things, ever-expanding social networks, and future sensor networks.
In parallel with the hardware development of a HIVE processor, DARPA is working with MIT Lincoln Laboratory and Amazon Web Services (AWS) to host the HIVE Graph Challenge with the goal of developing a trillion-edge dataset. This freely available dataset will spur innovative software and hardware solutions in the broader graph analysis community that will contribute to the HIVE program.
The overall objective is to accelerate innovation in graph analytics to open new pathways for meeting the challenge of understanding an ever-increasing torrent of data. The HIVE program features two primary challenges:
The first is a static graph problem focused on sub-graph Isomorphism. This task is to further the ability to search a large graph in order to identify a particular subsection of that graph.
The second is a dynamic graph problem focused on trying to find optimal clusters of data within the graph.
Both challenges will include a small graph problem in the billions of nodes and a large graph problem in the trillions of nodes.
Transhuman Code authors discuss digital ID’s and a centralized AI-controlled society. In 2018 More info SOURCE
To be continued? Our work and existence, as media and people, is funded solely by our most generous supporters. But we’re not really covering our costs so far, and we’re in dire needs to upgrade our equipment, especially for video production. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
As US media can’t be trusted with anything, I looked up mostly Eastern sources and came up with the full story of the lowest point in US history since 9/11.
This is the story of how China snatched Afghanistan from U.S. without firing a single bullet. Watch this, then I’ll contextualize even more.
Later update: Some readers rightfully suggested I haven’t highlighted enough the Afghani natural resources and their importance. So I made a follow-up video:
Wanna-be-green US has just handed global dominance on lithium and batteries to China. Why? See below
China in South Asia: The Case of Afghanistan
13 FEBRUARY 2018, by Lindsay Hughes, Research Analyst, Indian Ocean Research Programme, Ausralia Download PDF
Key Points
In Afghanistan, China recognises several economic and strategic opportunities to advance its goals in the region and beyond.
It sees the opportunity to acquire access to much of Afghanistan’s mineral wealth.
There is also an opportunity for China to ensure the security of its own restive Xinjiang Province.
Beijing also discerns a possibility to diminish US and Indian influence in Afghanistan.
Afghanistan, thus, almost demands China’s foreign policy attention.
Summary
It is almost trite to observe in 2018 that China’s economic growth over the last twenty-five or so years has been spectacular. The Chinese Communist Party, which has managed most aspects of the economy, can justifiably take credit for that growth. It has lifted an estimated six hundred million people out of poverty and enabled many others to become millionaires and even billionaires. If the sheer enormousness of that figure is difficult to comprehend, consider this: China used more cement between 2011 and 2013 than the United States used in the entire twentieth century. In other words, in the space of those three years, China constructed more housing and infrastructure than the United States did from the 1900s through to the 1990s, including its period of greatest expansion during which it built its Interstate road networks, the Hoover Dam and most of its skyscrapers. In those three years, China used an estimated 6.6 gigatons of cement compared to the United States, which used 4.5 between 1901 and 2000.
China’s economic growth has had a major effect on its foreign policy. In order for the Chinese Communist Party to be seen by the Chinese populace as not resting on its economic laurels, in being perceived to be pursuing the Chinese dream of returning the country to its historically pre-eminent position in the international order and in keeping with the one hundred-year marathon that Pillsbury describes, China now seeks to increase its influence in the region. While its efforts in that regard in the South China Sea and among the countries of South-East Asia have been recognised and analysed in considerable depth, its efforts to do likewise to its west have not received the same degree of attention.
China is actively at work in Kyrgyzstan and Tajikistan, attempting to stabilise those countries, and is now extending its reach into Afghanistan in order to achieve its regional goals. This paper will study some of those.
Analysis
Writing in 1975, Etzioni noted that ‘power differs according to the means employed to make [a] subject comply. These means may be physical, material or symbolic’, or what he terms coercive, remunerative and normative power. China employs these forms of power in different situations; for example, whereas in the South and East China Seas it uses coercive power more than it does the other forms, it relies more on remunerative power in Afghanistan. In other words, it buys its influence in that country.
The question that immediately flows from that observation is this: why does China seek to increase its influence in Afghanistan and Pakistan? What does it seek to achieve by doing so? The answer would appear to be economic gain. That is certainly true; China does seek economic reward by increasing its presence in these two countries. To limit that answer to mere economics would be short-sighted, however. The two countries need to be examined individually in order to better understand China’s motives.
China’s external relations policies are, like those of many other countries, an extension or outcome of its domestic situation. The Chinese Communist Party, in order to remain in power, has entered into an implicit agreement with the Chinese people that runs, more or less, along the lines of, “We will ensure that your economic circumstances are enhanced; in return, you will not question the legitimacy of our control over the country.” For economic benefits to flow, however, a country needs political stability. That is not assured in far-flung Xinjiang Province.
An estimated forty per cent of the people of Xinjiang belong to the Uyghur community; they are ethnically Turkic and mainly Muslim. They are different from the majority Han population in the rest of China (excluding Tibet) in their social structures, traditions and language, besides their religious ideology. As a consequence, the Chinese Communist Party, which does not countenance social differences it cannot fully comprehend, has sought to diminish the Islamic influence in the province. Apart from resettling Han Chinese in large numbers in Xinjiang, the Communist Party has imposed severe restrictions on the Uyghurs’ practice of their religion and their freedoms; mosques are barred from broadcasting the call to prayer; there are restrictions on the names that may be given to babies; the Muslim veil for women and beards for men are banned; the city of Karamay promulgated an ordinance that banned bearded men and women wearing burqas or hijabs from travelling on public buses; Uyghur drivers are often stopped and their identification papers and those of their passengers examined; their mobile phones are searched for content and applications that are deemed, arbitrarily in many instances, to be a threat to national security; Uyghur civil servants, students and teachers are prevented from fasting during the Ramadhan period and restaurants are forced to remain open. Schools are forced to conduct lessons in Mandarin and not Uyghur. These restrictions and often blatant violations of the rights accorded to other Chinese citizens have rankled in the Uyghur community. Arguably worst of all, the Communist authorities offer the Uyghur people cash and other incentives to intermarry with Han people, leading to a commonly-held perception in the Uyghur community that it is a blatant attempt to breed it out of existence.
The repressive measures have led to fatal attacks by Uyghur groups on Han Chinese, leading to a vicious circle of further repression and violence. Beijing is acutely aware, however, of the need to pre-empt any attacks by the Uyghurs’ co-religionists in Afghanistan or Pakistan, whether those be members of the Taliban or ordinary Muslim citizens who object to the repression of the Uyghurs, on its energy pipelines that originate in Gwadar and flow through to Xinjiang. To that end, it has sought to mitigate any perceptions of it being a repressive, authoritarian regime by seeking to develop, in the first instance, a strong economic relationship with Kabul.
It is no coincidence that China has sought to acquire mining rights in Afghanistan. As a previous FDI paper observed:
It was reported (and elsewhere, including here) in 2010, that the Pentagon believed that Afghanistan’s untapped mineral wealth could be worth around US$1 trillion. According to another report, the Afghan Government declared that figure to be around US$3 trillion but that figure is likely an exaggeration. According to the news report, a task force studying the country’s resources found that Afghanistan has significant deposits of copper, iron ore, niobium, cobalt, gold, molybdenum, silver and aluminium, as well as sources of fluorspar, beryllium and lithium, among others. While even the one trillion dollar figure may be exaggerated, the fact remains that the country does have enormous unexploited mineral wealth. Even if another country did not avail of the minerals itself (an unlikely possibility or outcome), there could be much profit to be had in partnering with still-to-be-established Afghan mining companies, by providing the technology and expertise required, for example, in the extraction of those minerals.
More specifically, it is the discovery of major lithium deposits in Afghanistan (one source provides an idea of the amounts of lithium available by referring to Afghanistan as “the Saudi Arabia of lithium”) that is of consequence. The original Pentagon report, while stating that the main minerals found were iron ore (estimated value US$421 billion) and copper (US$273 billion), was careful to note that the trillion dollar figure did not include known oil and gas reserves or the value of minerals like lithium that have not been verified to an extent that would permit a dollar figure estimation. While two Chinese firms have committed themselves to a US$4 billion investment in the vast Aynak copper mine, south of Kabul, it is the lithium deposits that are of strategic interest.
In the past few years, the demand for lithium has exploded along with the growth of lithium-ion battery technology in mobile phones, personal digital assistants, laptop computers and, more recently, electric vehicles and batteries that can be attached to solar-powered systems. China, which seeks to position itself as a major electric-powered automobile and solar panel manufacturer, could see its plans disrupted and, more importantly, at the mercy of, for instance, American firms that might come to control lithium production in Afghanistan.
The issue is especially acute for China, given the American presence in the form of its troops and “advisers” in Afghanistan.
In order to vitiate any advantage that the Americans may have in Afghanistan, China is talking not only to the Afghan Government but also to some Taliban groups. The approach appears to have been successful. While the government has cracked down on illegal mining, thus enabling Chinese mining companies to expand their operations, the Taliban has assured the Chinese firms that they need have no fear of attacks by its members and also offered to protect at least one mine and several gas projects with its members. While this has caused some discomfort in the government, which says that it has the sole right to grant mining leases and protect the ensuing operations, the Chinese companies remain secure in the knowledge that their operations can continue with minimal fear of being attacked. China appears to be reaping further dividends with its approach; an uncorroborated report has it, furthermore, that Afghanistan has recently announced that American mining companies would not be given licences to conduct operations there. This announcement comes despite reports of another major find in Afghanistan: huge deposits of potash.
Establishing a good relationship with Afghanistan also helps China to reduce American influence there. In fact, the visit by the Afghan Foreign Minister, Zalmay Rasoul, to Beijing in May 2011 saw a growing relationship between the two countries formalised just as then President Obama was preparing to reduce the number of American troops there. Chinese Foreign Ministry spokeswoman Jiang Yu spoke of Chinese support for the Afghan Government as it struggles to end instability and crushing poverty and noted China’s appreciation of Afghanistan’s ‘assistance on major issues bearing on China’s core interests’, a reference to Chinese territorial claims, especially in Xinjiang and Tibet that border the volatile Central Asia.
That meeting was among the first of many that followed. In December 2017, China hosted a trilateral meeting with the foreign ministers of Afghanistan and Pakistan. Chinese Foreign Minister Wang Yi met with Salahuddin Rabbani and Khawaja Asif, his Afghan and Pakistani counterparts respectively. Going against its stated policy of not interfering in the internal politics of other nations and demonstrating the country’s new-found confidence in its ability to play a much larger role in international politics, Mr Wang sought to bring the two governments together to resolve their differences. While he was only partially successful, Mr Wang did elicit promises from both to continue with their dialogue. That meeting was followed only days later by a meeting between the Defence Ministers of Afghanistan and China, which ended with a statement that the two sides had worked to ‘deepen pragmatic co-operation in various fields including anti-terrorism operations, and push forward the state and military relations between the two countries’. It is interesting to note that both meetings ended with statements regarding co-operation in anti-terrorism initiatives, an indication of how nervous Beijing is about terrorism in Central Asia spilling over into Xinjiang.
China is acting to mitigate those fears. In keeping with its policy of bringing bordering countries under its influence economically and militarily in progressive stages, China is now in discussions with Afghanistan to establish a military base there. It has been reported by many sources that Beijing is in talks with Kabul to construct a military base in Afghanistan’s remote and mountainous Wakhan Corridor, where witnesses have reported seeing Chinese and Afghan troops on joint patrols. Beijing allegedly fears that exiled Uyghur members of the insurgent East Turkestan Islamic Movement use the Wakhan Corridor to cross into Xinjiang to carry out attacks there. Beijing also worries that Uyghurs who were trained by and fought for Islamic State are now fleeing Iraq and Syria and could, similarly, use the Wakhan Corridor to enter China. Beijing is correct in fearing that these various groups and factions could amalgamate, based on their ethnicity and dislike of Chinese repression, and foment further unrest in Xinjiang.
A few other Chinese objectives in Afghanistan are worth noting. First, just as it hopes to reduce American influence there, Beijing also wants to reduce Indian influence in the country. New Delhi, which has a strong relationship with Kabul, is detested by Islamabad, which works to reduce Indian influence in the region in which it seeks “strategic depth” in the event of an Indian attack. China, for its part, seeks to isolate India in South Asia in a zero-sum game for influence in that region.
Second, China would want to create an alternative route for its Belt and Road Initiative through Afghanistan, a country that it could better influence than, say, Kazakhstan, which a resurgent Russia, for all its messages of friendship with China, would not readily permit, since Moscow sees Astana as being in its own zone of influence. China recognises the risks associated with a BRI route running through Kazakhstan and would wish to avoid that. Afghanistan offers an option. An Afghanistan route also enables China direct overland access to the gas fields of Iran. That could eliminate even the comparatively minor risks associated with piping oil and gas through Pakistan, such as attacks upon the infrastructure and personnel by Balochi insurgents and even by India in a conflict with Pakistan. Islamabad undoubtedly recognises, in turn, the risks that Afghanistan poses to the China-Pakistan Economic Corridor and Chinese investment in it.
Finally, by bringing Afghanistan into its zone of influence, China could create another market for its manufactured goods. At a time when it sees its exports dwindling, and in light of the Trump legislation on reduced company taxes in the United States, which has resulted in increased investment in that country’s manufacturing sector, China would want to avail itself of every market it possibly can.
To conclude, Afghanistan offers China several major economic and strategic opportunities. It requires no great deal of thought to recognise the viability of those. China would, almost unreservedly, seek to use those opportunities to further its agenda in the region and beyond.
*****
This above is still not the full picture. You also need to be aware of the following historical facts:
And in parallel with the storyline above, another one was at play:
As Israel and the US are just Rothschild enterprises and CCP a long-time partner to them, if you combine the two storylines it’s safe to safe to conclude:
The Rothschilds may not own everything and everyone but they have enough leverage to persuade anyone into an alliance. This one with the CCP has been in works for decades, they’ve incubated and supported this regime since the early days and, as it proves more fruitful than owning America lately, the human farm administration entered a longer process of reform. Biden is just the valet who delivered the keys to the new admin. And he wasn’t alone in this, he’s not the only Rothschild puppet there, see
And see that there are some agendas that each president has continued from his predecessors, sometimes against own political promises and ideology.
Afghanistan may be one of the lowest points in the US foreign policy history and a massive drama for Americans, but it’s just an episode to them, many more to follow. According to Biden, Americans have bigger worries right now:
Leave it to China to persuade them to mask and vaxx, mark my words!
To be continued? Our work and existence, as media and people, is funded solely by our most generous supporters. But we’re not really covering our costs so far, and we’re in dire needs to upgrade our equipment, especially for video production. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
To be continued? Our work and existence, as media and people, is funded solely by our most generous supporters. But we’re not really covering our costs so far, and we’re in dire needs to upgrade our equipment, especially for video production. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
Sometimes my memes are 3D. And you can own them. Or send them to someone. You can even eat some of them. CLICK HERE
Aliko Dangote Foundation The Alphawood Foundation The Andrew W. Mellon Foundation Aphorism Foundation AT&T Lynne & Marc R. Benioff The Bluhm Family Charitable Foundation Blum-Kovler Foundation/Peter & Judy Kovler The Boeing Company Amy & Joshua Boger The Eli & Edythe Broad Foundation John & Jacolyn Bucksbaum Family Foundation The California Endowment Sonya & Tom Campion Marcy Carsey The Chicago Community Trust* Robert & Jane Clark Stephen Cloobeck Colleen & Bradley Bell Charitable Foundation Ron Conway Family James Crane & Whitney Wheeler Crane The Crown Family Ann & John Doerr Ray & Dagmar Dolby Family Fund The Donovan Family Exelon Corporation Fred Eychaner Tony Fernandes Fidelity Charitable (4) The Ford Foundation Bill & Melinda Gates Foundation The Gibbons Scattone Family Foundation Scott Miller & Tim Gill The Goldberg Family Foundation The John & Marcia Goldman Foundation Lisa & Douglas Goldman Fund Goldman Sachs Philanthropy Fund Kenneth C. Griffin Charitable Gift Fund Agnes Gund The Harris Family Foundation The Hauptman Family Foundation Health Care Service Corporation Mel Heifetz Michelle Yee & Reid Hoffman Barbara & Amos Hostetter Andrew Houston Hutchins Family Foundation Iger Bay Foundation Illinois Tool Works Irving Harris Foundation–Joan Harris Hamilton & Amabel James The Jewish Communal Fund The Joyce Foundation JP Initiative, LLC Kapor Center for Social Impact Masimo Foundation for Ethics, Innovation & Competition in Healthcare Jonathan & Jeannie Lavine, Trustees Jeff & Erica Lawson Ambassador Fay Hartog-Levin & Daniel Levin The Reginald F. Lewis Family Foundation, Inc. Hobson/Lucas Family Foundation John D. & Catherine T. MacArthur Foundation Joe & Rika Mansueto Demond & Kia Martin Foundation McCormick Foundation Katie McGrath & J.J. Abrams Family Foundation Microsoft Corporation Scott Nathan & Laura DeBonis New York Community Trust Nike Foundation President Barack H. Obama & Mrs. Michelle Obama The Oprah Winfrey Charitable Foundation Todd Park & Amy Geng The Parker Foundation Polsky Foundation Jeanne & John Kevin Poorman through JKP Family Foundation Linda & Richard Price Family Fund Pritzker Traubert Foundation Prudential Foundation Rattner Family Foundation Rhimes Family Foundation Richard Paul & Ellen S. Richman Private Family Trust Foundation Robert & Jane Toll Foundation Victoria & John Rogers Rosenthal Family Foundation Amy & Kirk Rudy Cari & Michael J. Sacks Schlosstein Hartley Foundation Barbara Schmidt Service Station Foundation* The Share Fund II at The Tides Foundation* Beth & David Shaw Jon & Kimberly Shirley Silicon Valley Community Foundation Ian Simmons through ImpactAssets Donor Advised Fund Marilyn & Jim Simons Someland Foundation Steans Family Foundation Mrs. Marjorie Susman & Ambassador Louis B. Susman Sandra & John W. Thompson Laurie & Jeff Ubben Evan Williams & Sara Morishige W.K. Kellogg Foundation The Anne Wojcicki Foundation (YouTube CEO sister, Google owner partner and ex-wife) Kate Capshaw & Steven Spielberg’s The Wunderkinder Foundation Wayne Jordan & Quinn Delaney Mary & Jeffrey Zients Robert & Carol Wolf Family Foundation
$500,001 to $999,999
Cindy & Alan Horn Jill & Avram Glazer
$250,001 to $500,000
Ms. Patricia Passmore Alley The Atlantic Philanthropies* James & Mary Bell Mark Bergman & Susan Gibson The Brin Wojcicki Foundation (Same Google love triangle as above) Vinton Cerf & Sigrid Cerf Christine & John Bakalar Charitable Fund Tim Collins Lester, Chanel, & Javon Coney Don & Anne Edwards Charitable Fund Dr. Felice Frankel Connie & Sankey Williams The Jewish Communal Fund Nicholas & Monica Logothetis The Philip & Tammy Murphy Family Foundation Alison & Mark Pincus Kim & Nicholas Romano Dona & Sam Scott Foundation John Shulman & Alison Bernstein Shulman Silicon Valley Community Foundation Barbara Stiefel
$100,001 to $250,000
The Alter Group Michael & Ellen Alter Anne & Bruce Strohm Family Giving Fund Jay Kriz Blahnik & Ryan Kriz Blahnik+ Jedd & Dara Canty Edward & Paula Fearon FedEx Corporation Fisher Family Foundation Jason & Crystal Goldman Brett J. Hart & Dontrey Britt-Hart Ambassador Bruce Heyman & Vicki Heyman* Horowitz Family Foundation Ambassador Ronald Kirk & Mrs. Matrice Ellis-Kirk Lewis-Sebring Family Foundation, Charles Ashby Lewis & Penny Bender Sebring Lisa Stone Pritzker Family Foundation* Edward & Paula Hughes Pamela & William Hurley Karla Jurvetson Tom Kartsotis The Kresge Foundation Minow Family Foundation Thomas Nides & Virginia Moseley Gilbert Omenn & Martha Darling Ulice Payne, Jr. The Rockhaven Charitable Fund Skoll Foundation Stripe, Inc. Andrew Tobias Ranvir & Adarsh Trehan/Trehan Foundation The San Francisco 49ers Kevin Xu The University of Chicago The Rumi Foundation Aaron & Ana Zamost
$10,000 to $100,000
Jim & Wendy Abrams Rona & Jeffrey Abramson Marcie & Nick Alexos Jack Alotto Alpenglow Foundation A.L. Mailman Family Foundation Melissa Alvarado* AMC Networks* Amy & Michael Tiemann Charitable Gift Fund The Apatow-Mann Family Foundation, Inc. John Atkinson & Bonnie Atkinson Atlantic Fellows for Racial Equity at Columbia University Priya V. Balakrishnan Rye Barcott Charles Barkley Baskin Family Foundation Corinne Anne Basler Bob Baxley* Big Win Philanthropy Dr. Anita Blanchard & Martin Nesbitt John Boiler & Kari Boiler Pamela Bass-Bookey & Harry Bookey Andrew & Ellen Bradley Brayton Family Charitable Fund Douglas & Teresa Brown John & Carla Brozovich Burch Giving Fund Dwight & Antoinette Bush Calendly LLC* Casey Family Programs Beverly Castleberry Christine Chang The Cheka Fund at The Miami Foundation* Lila Cherri Chuck Lorre Family Foundation James Clark Craig Newmark Philanthropies Jesse Crowe The Patricia Crown Family Stephen & Ayesha Curry Family Foundation Beverly Dale Gilbert Omenn & Martha Darling Deutscher Evangelischer Kirchentag Michael Donaghue Jackie Brown Duncan Judith Estrin The Fine & Greenwald Foundation Paul & Mary Finnegan Franklin & Marshall College Dave Free* Eiichi Fukushima Drs. Helene D. Gayle & Stephen N. Keith Steve & Lisa Gerber Robert & Susan Glovsky Fund The Goolsbee Family Mark Gordon Barbara Grasseschi & Anthony Crabb Anastasia Greene* GRoW @ Annenberg Hamlin Kurihara Fund Harry & Jeanette Weinberg Foundation Megan Holmes Estate of Nancy Hom John Hynes Inner Loop Capital* Jack & Jill of America Foundation, Inc. Kenneth & Lisa Jackson Paul & Catherine Jefferys Fund Luci Baines Johnson Debbie Johnston Charitable Gift Fund* Heather Jones Manju Karkare & Jayant Khadilkar Kate Somerville Skincare LLC* John & Jennifer Kelly* John Lamonica Lawrence Z. & Jaqueline A. Stern Foundation Rodney & Sue Lee Jane A. Lehman & Alan G. Lehman Foundation John & Jill Levi Leslie Lewis Mr. Jeremy Liew & Ms. Ranee Lan The Lostand Foundation Susan Lubetkin Joseph Macari Marin Community Foundation Jane & Richard Mescon Weston Milliken The MJK Family Foundation Robert Rivkin & Cindy Moelis The Museum of Ice Cream on Behalf of AlunaGeorge Nancy E. Myers The National Association of Basketball Coaches Foundation The Nayar Family Foundation NBA Players Association Foundation Doris J. Newton Marti Noxon* The Oakland Athletics The Opportunity Fund Ambassador Robert & Mitsuko Orr Peter Orzsag Pamela Valinet Charitable Mary & David Peirce* Penny Norman Trust Carol & David Pensky Kathryn Petit Mr. Anh Pham The Phillips Family Hasmit Popat Lauri Altman Posner & Brian Posner* Kevin Quail Thomas & Sheila Rabaut Revada Foundation The Revlis Foundation The Friedman Family Georgina T. Russo Juan Sabater Salesforce.org Mrs. Bettylu Saltzman & Dr. Paul Saltzman Shiva Sarram & Drew Pearson* Mr. Andrew Schapiro & Ms. Tamar Newberger Margaret Schink Segal Family Foundation Eugene Sepulveda & Steven Tomlinson Mary & Charles Sethness Charitable Foundation Susan D. Shenk* Ruth Simmons Diane Meyer Simon Simply Southern* Charles Smith Hortense Snower Ken & Lissa Solomon Neil & Carla Subin* Suvoda LLC* Suggs Family Foundation Susan Sher & Neil Cohen Fund at The Chicago Community Foundation Chade-Meng Tan Pedro Torres-Mackie Craig Troyer Jeremy Tworek Under Armour, Inc* Christopher P. Valenti Charitable Fund Glen de Vries* Lester Ward Giving Account Wachtell, Lipton, Rosen & Katz* Warner/Roback Family Fund* Weinberg-Newton Family Foundation Sherrie & David Westin The Wildbasil Fund Jae Yu* Barry & Lisa Zimmermann* Bruce Carbonari*
* Donors who have made new cash contributions or formalized written commitments between April 1 – June 30, 2020. + Donors who have included the Obama Foundation in their estate plans.
To be continued? Our work and existence, as media and people, is funded solely by our most generous supporters. But we’re not really covering our costs so far, and we’re in dire needs to upgrade our equipment, especially for video production. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
I had to pull out the colored crayons as the world is a kindergarten.
LATER UPDATE: VIDEO VERSION READY, IT GOES EVEN DEEPER…
This is your virus, one of the versions, but it has only proven to exist in form of a salad of four characters shaped as a genetic code. SOURCESOURCE
When you ask about virus Gold-Standard evidence, aka purification and isolation as per Koch’s Postulates, they give you “cultures”. That’s like saying you discovered a new species of primate but you can only show a jungle.
That letter salad was fed into a computer program which generated the formulations for injections in mere hours, as the industry bragged:
Proving the virus is bullshit had never been easier:
Now, the more you investigate other viruses, the more you have similar surprises. And that goes for 99% of what you hold true.
Especially the slavery
Don’t trust what I say, research it.
To be continued? Our work and existence, as media and people, is funded solely by our most generous supporters. But we’re not really covering our costs so far, and we’re in dire needs to upgrade our equipment, especially for video production. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
Hundreds of Native American tribes that have suffered disproportionately high addiction and death rates during the opioid epidemic agreed on Tuesday to a tentative settlement of $590 million with Johnson & Johnson and the country’s three largest drug distributors.
Together with a deal struck last fall between the distributors and the Cherokee Nation for $75 million, the tribes will be paid a total of $665 million. Purdue Pharma has already committed at least tens of millions more to the tribes in a settlement that is in mediation.
“We are not solving the opioid crisis with this settlement, but we are getting critical resources to tribal communities to help address the crisis,” said Steven Skikos, a top lawyer for the tribes.
Native Americans have endured disproportionately high opioid-related overdose deaths, by many metrics. In 2016, for example, Oglala Lakota County in South Dakota, home to the Oglala Lakota tribe, had an opioid-related death rate of 21 people per 100,000, more than twice the state average. According to one study, pregnant American Indian women were as much as 8.7 times more likely than pregnant women from other demographic groups to be diagnosed with opioid dependency or abuse.
The contours of the new settlement, announced in the U.S. District Court in Cleveland, the seat of the national opioid litigation, are similar to an agreement that the companies struck with state and local governments last summer.” – NYT
To be continued? Our work and existence, as media and people, is funded solely by our most generous supporters. But we’re not really covering our costs so far, and we’re in dire needs to upgrade our equipment, especially for video production. Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!
! Articles can always be subject of later editing as a way of perfecting them
As Klaus Schwab promised, The Great Reset / 4th Industrial Revolution is “a tsunami of digitalization”. Sorry I didn’t have time to make a story today, life’s hard and likely short now. However, the resources below follow a storyline.
Since 2014, the Smart Water Summit has been bringing Vendor Partners together with North American Water Utilities – in an intimate setting to begin updating technology and improving North American Water Utility Infrastructure. The Smart Water Summit is a quality, hands-on experience where high level Utility Executives interact with Industry Leading Vendors, analysts and federal agencies. Summit Attendees are able to stay current with the latest advances in technology by participating in Vendor Boardroom Presentations, The Summit Solution Showcase, and Executive Premier Presentations.
They’re simply spying on the waste-water and, if you pay attention they’re not just screening for viruses!
Researchers at The University of Manchester’s National Graphene Institute (NGI) have achieved a long-sought-after objective of electrically controlling water flow through membranes, as reported in Nature.
This is the latest exciting membranes development benfitting from the unique properties of graphene. The new research opens up an avenue for developing smart membrane technologies and could revolutionise the field of artificial biological systems, tissue engineering and filtration.
Graphene is capable of forming a tuneable filter or even a perfect barrier when dealing with liquids and gases. New ‘smart’ membranes developed using an inexpensive form of graphene called graphene oxide, have been demonstrated to allow precise control of water flow by using an electrical current. The membranes can even be used to completely block water from passing through when required.
Is this what water does after attending classes at a liberal college? We need to find the location of these people to see if they got any ‘smart water’ projects going on there!
The team, led by Professor Rahul Nair, embedded conductive filaments within the electrically insulating graphene oxide membrane. An electric current passed through these nano-filaments created a large electric field which ionises the water molecules and thus controls the water transport through the graphene capillaries in the membrane.
Prof Nair said: “This new research allows us to precisely control water permeation, from ultrafast permeation to complete blocking. Our work opens up an avenue for further developing smart membrane technologies.
“Developing smart membranes that allow precise and reversible control of molecular permeation using external stimuli would be of intense interest for many areas of science; from physics and chemistry, to life-sciences.
The achievement of electrical control of water flow through membranes is a step change because of its similarity to several biological process where the main stimuli are electrical signals. Controlled water transport is a key for renal water conservation, regulation of body temperature and digestion. The reported electrical control of water transport through graphene membranes therefore opens a new dimension in developing artificial biological systems and advanced nanofluidic devices for various applications.
Previously, the research group have demonstrated that graphene oxide membranes can be used as a sieve to remove salt from seawater for desalination alternatives. Last year they also showed that the membranes could remove the colour pigment from whisky without affecting its other properties.
For the ground breaking research in graphene-based membranes, Professor Andre Geim and Professor Rahul Nair have won 8th Award of the Prince Sultan Bin Abdulaziz International Prize for Water (PSIPW)
Scientists have long been trying to control water flow through membrane by using an external stimuli due to its importance for healthcare and related areas. Currently, such adjustable membranes are limited to the modulation of wetting of the membranes and controlled ion transport, but not the controlled mass flow of water.
Dr. Kai-Ge Zhou, lead author for the research paper said, “The reported graphene smart membrane technology is not just limited to controlling the water flow. The same membrane can be used as a smart adsorbent or sponge. Water adsorbed on the membrane can be preserved in the membrane even in desert conditions if a current is applied. We could release this water on demand by switching the current off.”
Dr. Vasu, second lead author commented, “Our work not only opens new applications for graphene membranes but it allows us to understand the effect of electrical field on the nanoscale properties of confined water. Despite many conflicting theoretical predictions ranging from freezing of water molecules to melting of ice under an electric field, the experimental evidence for electric field effects were missing. Our work shows that large electric field can ionise water in to its constituent ions.”
The work was done in collaboration with scientists from the University of York, Shahid Rajaee Teacher Training University, Iran, and the University of Antwerpen, Belgium.
Graphene and related two-dimensional materials have shown promise for developing new applications as well as enhancing currently used processes for areas as diverse as; electronics, composites, sensors and biomedical. Membranes have become as key research and development theme for desalination, gas separation and healthcare.
The Premier Forum for Water Leakage and Smart Water Technologies
Welcome to the Smart Water Utilities USA 2021 Exhibition and Conference where global water utilities and network services will meet with water leakage experts and smart water technology providers in California to explore efficient and cost-effective solutions for the water utilities industry.
Water is one of the most valuable resources across the globe and as rapid urbanisation has led to the rise in water demand, pressures across the water network caused by climate change and an ageing infrastructure have significantly impacted the availability of water. Non-revenue water (NRW) is water that is lost before it reaches end users, with water leakage being a key contributor of global water loss, currently valued at $40 billion per year, which is now driving the demand for smart technology solutions.
The face of water supply networks is fast changing as operators navigate through the ‘digital water age’ and introduce new technologies across their water networks with advances in IoT and AI for network automation and control to efficiently manage and reduce water leakage. As operators work to meet new regulations and leakage targets, new initiatives towards more efficient water networks have become essential in order to satisfy an ever-increasing demand for water.
With new developments in smart water technologies and technical know-how, recent advancements in leak detection offer new hope for water companies looking for operational efficiencies under challenging market conditions, and to better manage their water networks. The Smart Water Utilities USA 2021 event is set to become the region’s leading exhibition and conference exclusively for water companies and smart water technology experts, to present new solutions for water leakage and how to develop smarter systems across their water networks.
The key focus for this year’s conference will be to “efficiently manage and reduce water leakage”, and the objective will be to bring water utilities and network services together with leading industry experts to collaborate and examine new opportunities in smart water technologies, and to address the key challenges in water utilities from a global perspective.
Key topics on this year’s agenda include:
Making an economic assessment for water utilities development
Integrating smart water technologies into existing water infrastructure
Strategies for managing and reducing water leakage across the network
Looking at real-time data and cutting-edge communication technologies
New technologies and know-how in IoT and AI for network automation
End-user case studies and how to develop an optimal network
This exhibition and conference will provide a forum for all stakeholders from water utilities and network service providers to leading water leakage experts and smart technology companies, to network and build cross-market relationships, and to discuss the latest results in smart water networks for the benefit of the water utilities industry.
Milestone contract for graphene technology in water treatment
G2O is a fast-growing technology business with a portfolio of products that reduce the cost and environmental impact of water treatment. Our products harness the transformational potential of 2D materials, such as Graphene Oxide.
UK technology business G2O Water Technologies has landed its first commercial contract for the enhancement of water filtration membranes with graphene oxide. This is particularly significant for both the technology company as well as the water sector globally, as it is the first commercially successful application of the recently developed “wonder” material for water treatment.
The advantages of using graphene oxide lie in the enhancement of membrane performance, as it mitigates the effects of fouling – one of the biggest challenges operators of membrane-based water filtration systems face. With a coating of graphene oxide, successfully developed and piloted by the company in the northwest of England in collaboration with Hydrasyst Limited, operators can improve operational efficiency, reduce energy consumption and decrease chemical usage. It is anticipated that this will extend the lifetime of the membranes, as well as significantly reducing the cost and environmental impact of water treatment.
Hydrasyst, the earliest adopter of the technology, is a British turnkey solution provider of advanced membrane technology systems, particularly in industrial processes. Commenting on its work with G2O, Managing Director Kyle Wolff stated, “We’re thrilled to have been closely involved for some time now with the piloting and application of G2O Water Technology’s graphene oxide coatings. They have ultimately succeeded in proving their value for some of the most difficult water treatment challenges our customers face; for example in the industrial laundry sector. With the graphene oxide coating, our ceramic hollow-fibre membrane systems deliver significant operational advantages, enabling end-users to enhance the efficiency of their water usage, whilst delivering significant savings in energy costs .”
“This is a significant milestone for the company and the whole water sector. It’s the first commercially successful application of graphene oxide for water treatment”, said Chris Wyres, CEO of G2O Technologies. “The results of industrial trials with Hydrasyst validate the real-world advantages the solution delivers. We will be working closely with Hydrasyst to roll-out Nanopulse systems for a range of water treatment applications. We envisage that wide-scale deployment of this transformational solution can contribute to addressing the challenges of water scarcity and climate change.”
UK technology business completes equity funding boost
Investors back G2O to accelerate growth
Significant potential demonstrated in industrial, oil and gas, food & beverage and energy sectors
UK technology business G2O Water Technologies recently completed an equity funding round, with existing and new investors backing the business to accelerate growth.
G2O’s innovative graphene oxide coating products that reduce the cost and environmental impact of water treatment, have developed significant market traction, with a rapidly growing pipeline of opportunities across a broad range of sectors including industrial, oil & gas, food & beverage and domestic water filtration.
Chris Wyres, CEO of G2O stated “Strong market traction for our Graphene oxide coating products has enabled us to secure additional capital from investors to accelerate growth and delivery of the strong pipeline of opportunities we have generated. As part of this strategy, we will be expanding our facilities and team, ramping up marketing and business development and commercialising an exciting range of new products.”
The company will be focusing on converting a rapidly growing pipeline of opportunities, gearing the business to support partners and expedite progression through prototyping and industrial testing. G2O are currently applying their innovative technology to solve critical challenges in a broad range of water treatment processes, including desalination and the oil and gas, food and beverage and energy sectors. In each case, the proven solutions deliver enhanced operational efficiency, reducing energy costs, maintenance and chemical usage, as well as extending the lifetime of the membranes. This enables end-users to not only reduce costs, but also to minimise their environmental impact and contribute to addressing climate change.
“We’re delighted that all our current investors have recognised the excellent progress made by the company in the last 12 months and have continued to support us. It is also a pleasure to welcome our new industrial investors to G2O, which is a tremendous vote of confidence in the future of the company. The timing of this investment comes as the company has just achieved a key milestone with the signing of its first commercial licensing agreement and I look forward to an exciting future as we progress through to full scale commercialisation of the technology with our development partners.” commented Andrew Greenaway, Chairman of G2O
Smart water-based ferrofluid with stable state transition property: Preparation and its application in anionic dye removal
This article reports a smart water-based ferrofluid that can transform from stable state to unstable state for separating the contained magnetic nanoparticles after use.
The ferrofluid is synthesized by preparing polyethylenimine modified Fe3O4 nanoparticles via a one-pot method, and then improved by acidification treatment and ultracentrifugation-based washing. The resultant ferrofluid and intermediate products have been systematically characterized, verifying that the ferrofluid possesses superparamagnetism, high saturation magnetization as well as strong colloidal stability, and the magnetic nanoparticles contained in the ferrofluid have small aggregation size, strong electropositivity and high saturation magnetization.
It has been confirmed that the acidification treatment and ultracentrifugation-based washing greatly activate the positive charge and reduce the aggregation size of polyethylenimine modified Fe3O4 nanoparticles, which is the key to our successful synthesis of this new type of ferrofluid. Furthermore, the adsorption behavior of the ferrofluid on the anionic Ponceau S dye has been systematically investigated, demonstrating that the ferrofluid can adsorb anionic Ponceau S dye in a short time (<5 min) with a maximum adsorption capacity of 140.26 mg/g.
The experimental data show that the adsorption kinetics follows the pseudo-second-order mode and the Langmuir isotherm model is applicable to describe the adsorption processes.
Importantly, the magnetic nanoparticles in the ferrofluid can be easy to separate from solution after adsorbing anionic Ponceau S dye, preventing secondary pollution and showing great potential in wastewater treatment.
GRAPHIL: The Future of Innovative Portable Household Water Filters
GRAPHIL, the new Spearhead project, brings together Icon Lifesaver (UK), Medica SpA (Italy) and Polymem S.A (France) along with other academic partners, Chalmers Institute of Technology (Sweden), Manchester University (UK), and the National Research Council (Italy). The consortium is committed to the production of innovative filters for household water treatment.
According to WHO and UNICEF, 2.2 billion people lacked access to safe drinking water in 2019 (United Nations, n.d.). Each year, approximately 88% of the four billion worldwide annual cases of diarrhea have been attributed to a lack of safe drinking water (Schroth, Lanfair, & Ambulkar, n.d.).
The Graphil project responds to the urgency of producing an easy to use microfiltration membrane that can be connected directly onto a household sink or used as a portable device for water purification. The filter is expected to go into the market in 2023 and can remove contaminants, pesticides, heavy metals, and dangerous pathogens from drinking water (Graphene Flagship, 2019).
Water Purification
The undesired chemical compounds, organic and inorganic materials, and biological contaminants, such as suspended particles, parasites, bacteria, algae, viruses, and fungi are removed from water through multiple physical, chemical, or biological processes (Schroth, Lanfair, & Ambulkar, n.d.).
In the United States, the safety of drinking water quality is regulated by the United States Environmental Protection Agency (EPA), whereas the European Union is regulated by Article 10 of the EU Drinking Water Directive (Directive 98/83/EC) (European Drinking Water, n.d.). On 18 February 2020, the environment and public health committee updated the EU rules of drinking tap water, which is expected to update quality standards and sets out minimum hygiene requirements for materials in contact with drinking water (European Parliament, 2020).
In Europe, most countries use chlorine as a drinking water disinfectant since the discovery of water disinfectant abilities in 1905 by the London Metropolitan Water Board. The U.S quickly followed the use of Chlorine, reaching 64% of all community water systems by 1995 (Centers for Disease Control and Prevention, 2015). According to the WHO, the standard drinking water state is 2-3 mg/L chlorine to achieve satisfactory drinking water (Lenntech, n.d.).
Portable Water Filtration
The filter membrane performance depends on the amount of water passing through the membrane per unit of time and surface area, and the concentration ratio of a component between the filtered particles and the feed water solution.
Following the discovery of Graphair (Smith, 2020), a conventional one-step water filtration system by a team of scientists from Commonwealth Scientific and Industrial Research Organization (CSIRO), graphene has successfully entered as a competitive next-generation solution for the portable water purification process. Graphair is a 4 cm2 graphene film filtration membrane with microscopic nano-channels that prevents larger contaminants such as salt enter the water (Bold Business, 2018). The filter was proved to be low-cost, removing 99% of impurities faster than other conventional filters without using chlorine.
Graphene as a Water Filter Membrane
Graphene’s large surface area, versatile surface chemistry, and exceptional mechanical properties allow it to bind ions and metals. This process reduces the number of inorganic contaminants in water. The graphene-based membrane also offers a simpler setup compared to other traditional membranes, such as reverse osmosis and microfiltration train systems, leading to lower operating pressure and maintenance costs for end-users.
Last year, the researchers from Russia’s National University of Science and Technology (MISiS), Derzhavin Tambov State University, and Saratov Chernyshevsky State University experimented with graphene oxide to purify water by injecting graphene oxide into E. coli containing saline solutions. The results demonstrated the bacterias forming flakes inside the solution along with the graphene oxide, which can be easily extracted, making water free of bacteria (Smart Water Magazine, 2019).
We are in an era where sustainability, energy savings, solar options, innovations, engineering and smart home tech knowledge are all extremely important to consumers, business leaders and employees trying to make a difference in the world. In 2018 alone, the U.S. spent $19.8 billion on smart home technology. I predict a new material called graphene will revolutionize the smart home industry and become a key factor in smart home technology advancements and innovations.
Although there have been attempts to study graphene since the mid-1800s, it wasn’t until 2004 when scientists discovered and isolated a single atomic layer of carbon for the first time. Since then, research has skyrocketed, and graphene is now considered to be the strongest substance known to science and might be one of the world’s most useful “wonder” materials.
Graphene forms a nearly transparent, flexible sheet about one atom thick (which, to put in perspective, is one million times smaller than the diameter of a single human hair). It is 200 times stronger than steel yet six times lighter. It is a conductor of electrical and thermal energy, and it is eco-friendly and sustainable, with unlimited possibilities to create the perfect smart home (and more).
Smart building
Concrete is the most common building material, along with steel, but greenhouse gas emissions from concrete and cement-making remain high. Cement-making accounts for 6 percent of global carbon emissions.
Use of graphene, when incorporated into concrete and cement, makes for a stronger, more water-resistant composite material that could reduce emissions. This material can be used directly on building sites, enabling the construction of strong and durable buildings using less concrete and reducing greenhouse gas emissions. This process reduces roughly half the amount of materials used to make concrete, all at a lower cost.
Smart paint
Imagine being able to paint your house with a special coating that changes color when it senses that the underlying structure is in need of repairs. Researchers have created a smart graphene coating that indicates breaks and fractures by changing color. This could revolutionize the home inspection process.
Graphene also has been used to make eco-friendly paint. Because graphene is a superconductor, the addition of graphene to paint can improve the thermal regulation of buildings, requiring less heating and air conditioning. Graphene’s inclusion in paints, coatings and other building materials greatly enhances strength, durability and coverage.
Smart solar
Solar panels on a home are a great source of energy. Graphene can be made into transparent solar cells that can turn virtually any surface into a source of electric power. This technology could give homeowners the opportunity to turn something like a garage door, window or roof into a solar conductor, all while maintaining the desired look of the home.
Smart light
Glowing walls could soon replace the light bulb, allowing for the introduction of glowing “wallpaper.” This would provide a more pleasant, adjustable light across a room compared to lightbulbs, and it can also be made more energy-efficient.
It’s also a highly efficient conductor of both heat and electricity and conducts electricity better than copper.
Smart sound
To produce sound, regular speakers create a pressure wave in the air by physically moving back and forth. Graphene can create a non-moving solid-state audio device that would eliminate the need for a large sound system and speakers.
Researchers believe they can incorporate speakers into ultra-thin touch screen technologies, in which the screen is able to produce sound on its own and could probably be incorporated onto walls.
Smart battery
Graphene can make batteries that are light, durable and suitable for high capacity energy storage, as well as shorten charging times. It will extend the battery’s lifetime and will add conductivity without requiring the amounts of carbon that are used in conventional batteries. Graphene can also be used to create new batteries that recharge quickly.
Smart water
Water conservation is a high priority in our country. It is expected that by 2020, 25 million people (in seven states), including Arizona and Nevada, will be forced to cut back on water usage as Lake Mead and Lake Powell essentially run dry. Graphene membranes can be used as water filters, filtering 85 percent of salt out of seawater.
Although this percentage is not quite pure enough for drinking purposes, it is perfect for agricultural and landscaping use. This can help regions affected by the drought, that are located near large bodies of water and maintain modern, low-water landscaping using a better eco-friendy solution.
Combining all of graphene’s amazing properties could create a holistic impact on the world of smarter homes, and its participation as a change agent is not far away.
Household Water Filtering
The Water Resource Group notifies that the worldwide water supply-to-demand gap is likely to reach approximately 40% by 2030, which warns the issue of water scarcity to be a worldwide priority.
Although already-existing water filtration methods shown in the following table have controlled the market (European Commision, 2010), they are expensive, complicated or highly inaccurate, which prevents most parts of the world from getting access to clean drinking water. (Shull, 2012):
Filtration Method
Particle Capture Size
Contaminants Removed
Microfiltration
0.1-10 µm
suspended solids, bacteria, protozoa
Ultrafiltration
ca.0.003-0.1 µm
colloids, proteins, polysaccharides, most bacteria, viruses (partially)
Nanofiltration
ca.0.001 µm
viruses, natural organic matter, multivalent ions
Reverse Osmosis
ca.0.0001 µm
almost all impurities, including monovalent ions
The Graphil project has helped to develop affordable and easy to use portable or household water filters. According to Mrs. Letizia Bocchi, who is the leader of the project, their filters are made with hollow plastic fiber membranes blended with graphene to enhance the adsorption of chemical contaminants (Diamante, 2020). Once completed, the Graphil filters could be directly mounted on a household water filtration system or portable water purifier devices, which also means a reduction in bottled water consumption, contributing to positive environmental impacts.
Shull, A. (2012). The Design and Creation of a Portable Water Purification System. [Online] Andrews University: https://digitalcommons.andrews.edu/honors/39 (Accessed on 04 October, 2020)
SILVIEW.media 
